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Endometriosis 
Endometriosis is an enigmatic gynecologic disorder that afflicts millions of 
women worldwide.  Present in menstruating mammals (i.e. human and non-
human primates), endometriosis is defined by the ectopic localization and 
establishment of endometrial tissue throughout the body, commonly founded on 
peritoneal surfaces [Benagiano and Brosens 1991].  Another common location of 
this tissue’s abnormal ectopic presence is on the surface of the ovary, termed 
endometriomas [Koger et al. 1993].  Histologically, the lesions are defined by the 
presence of stroma and epithelial glandular cells that respond to the milieu of sex 
hormones released cyclically throughout the menstrual cycle [Benagiano and 
Brosens 1991].  Responses include tissue growth and remodeling, localized 
angiogenesis and vasculogenesis, and a variable release of biochemical factors 
such as cytokines, matrix metalloproteinase 3 (MMP3) and prostaglandin E2 
alpha (PGE2α) [Karck, et al. 1996; Cox et al. 2001].  Lesions may appear as a 
variety of phenotypes, ranging from those that are active, maintaining a red, 
glandular appearance, to those that are inactive, exhibiting a white, fibrotic 
appearance [Kennedy et al. 2005].  According to the American Fertility Society 
(AFS), a female can exhibit one or more types of these lesions, regardless of the 
severity of the disease.  
Endometriosis Etiological Hypotheses 
There are several hypotheses concerning the etiology of endometriosis.  
The most cited is that of Sampson’s Theory of Retrograde Menstruation 
[Sampson 1927]. Sampson suggests that, during menstruation, a portion of the 
sloughed endometrial tissue ‘backflows’ through the oviducts and into the 
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peritoneal cavity instead of exiting the lower portion of the uterus.  This 
anomalously displaced endometrium may then transplant itself in an ectopic 
location and establish endometriotic lesions [Sampson 1927].  Interestingly, 
retrograde menstruation occurs in about 90% of women worldwide [Halme et al. 
1984].  This raises the question as to what specific biological factors cause lesion 
formation in some, but not all women with retrograde flow.   
Numerous studies have observed abnormal gene expression in both the 
eutopic and ectopic endometrium of endometriosis patients compared to healthy 
controls [Liu et al. 2011; Stilley et al. 2012].  It has not been yet determined which 
of these abnormalities is causal or an effect of the disease.  
Well-characterized mechanisms supporting Sampson’s Theory are known.  
For example, several members of the matrix metalloproteinase (MMP) family are 
implicated in the establishment of endometriotic ectopic lesions in the peritoneal 
cavity [Cox et al. 2001; Becker et al 2010].  Tumor necrosis factor alpha (TNFα) 
is known to activate MMPs, but suppress tissue inhibitors of metalloproteinases 
(TIMPs).  Increased TNFα in the peritoneal fluid (PF) of women with 
endometriosis plays a role in the elevated expression of MMP2 and 9 in lesions, 
leading to their increased ability to degrade the underlying peritoneal basement 
membrane and establish themselves [Gottschalk et al. 2000].  Also, the reduced 
functionality of natural killer (NK) cells and phagocytes observed in women with 
endometriosis has been predicted to lessen the body’s ability to remove 
abnormally located, potentially harmful tissue [Oosterlynck et al. 1991].   
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Nuclear kappa factor B (NFκB), an important transcription factor that 
responds to a variety of cellular stressors, is also upregulated in the PF of 
women with endometriosis [Defrere et al. 2011; Gonzalez-Ramos et al. 2012].  
Along with being partially involved in the increased expression of ectopic 
endometrial MMP3, NFκB also plays a role in mediating apoptosis due to its 
regulation of a variety of anti-apoptotic genes.  These include TNF- Receptor 
Associated Factor 1 (TRAF1) and TNF-Receptor Associated Factor 2 (TRAF2) 
[Sheikh and Huang 2003].  Constitutively expressed NFκB will lead to 
overexpression of these anti-apoptotic molecules, reducing the ability of the 
endometrial cells to undergo normal programmed cell death in the PC.  In turn, 
the elevated survival rate of retrograde menstruated endometrium may increase 
its ability to form characteristic endometriotic lesions within the PC.   
Another theory implicated in the pathogenesis of endometriosis is that of 
Robert Meyer [Gruenwald 1927].   This theory describes the metaplastic 
transformation of coelomic epithelium, a cellular ancestor of endometrial cells, as 
potentially triggered by an elevated inflammatory response.  This is potentially 
due to an excessive presence of certain cytokines such as interleukin-6 (IL6), 
interleukin-10 (IL10), and TNFα [Gomez-Torres et al. 2002].  This may lead to the 
establishment of endometriotic lesions in the peritoneal cavity of specific 
individuals, dependent upon their immune status.  Finally, one recent theory is 
that endometriosis may develop from stem cells present within the eutopic 
endometrium [Gargett et al. 2007; Chan et al. 2012].  Candidate endometrial 
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epithelial and stromal stem/progenitor cells are currently being evaluated 
[Gargett et al. 2007;  Sasson and Taylor 2008].   
Symptoms of Endometriosis 
The two primary symptoms of endometriosis are pain and infertility, which 
vary in severity between women.  For instance, women with endometriosis may 
suffer from an excruciating level of abdominal and/or back pain throughout their 
menstrual cycle while others will experience only a small amount of discomfort 
[Benagiano and Brosens 1991; Allaire 2006].  Also, while some of these women 
with endometriosis will become pregnant without assistance, others will undergo 
multiple cycles of assisted reproduction therapy (ART) without conceiving 
[Dokras and Olive 1999].   
There are many known causes of the abdominal pain exhibited by 
endometriosis patients.  Excessive levels of inflammatory factors and 
macrophages found in the peritoneal cavity of women with endometriosis act as 
contributing factors to this pain [Gonzalez-Ramos et al. 2012; Halme 1991].  This 
response is exacerbated by the cyclic retrograde shedding of the vascular, iron-
rich endometrium into the PF.   Menstrual fluid-red blood cell (RBC) lysis in the 
PC leads to an excessive presence of iron-rich hemoglobin, establishing a high 
prevalence of macrophages laden with hemosiderin, an insoluble form of stored 
iron [Van Langendonckt et al. 2002; Defrere et al. 2011] .  While necessary for a 
variety of oxidative-reductive reactions, abnormally high levels of iron can lead to 
oxidative injury and inflammation, amplifying the effects of macrophage-produced 
cytokines [Van Langendonckt, 2002].   
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It has been observed that women with endometriosis had significantly 
lower levels of hemopexin, an iron-binding protein present in blood plasma that 
typically prevents the toxic effects of free floating iron [Wolfler et al. 2013].  It can 
be suggested that varying hemopexin concentrations may be a contributing 
factor to why some women develop the disease, even though it is known that 
90% of the female population experiences retrograde menstruation [Halme et al. 
1984; Wolfler et al. 2013].   Also, an increase in nerve growth factor (NGF) 
secretion has been observed in the peritoneal fluid (PF) of women with 
endometriosis, suggesting that localized peritoneal production of NGF may be a 
risk factor for endometriosis-induced pain [Anaf et al. 2000; Tokushige et al. 
2007].  Nerve growth factor is involved in a number of different pathways, 
including neuronal survival, development, and function, along with being a 
mediator of inflammation [Frade and Barde 1998].  Finally, endometriotic lesions 
may cause adhesions to form between different organs (i.e. bladder and bowels) 
leading to tissue damage and organ misplacement [Benagiano and Brosens 
1991].  
Endometriosis causes a second detrimental phenotype in reproductive-
aged women: subfertility [Garrido et al. 2002].  It has been reported that 30 to 
40% of infertile women are diagnosed with endometriosis [Verkauf, 1987].  A 
large number of factors contribute to this subfertility.  Specifically, the increased 
presence of reactive oxygen species (ROS), induced by the prevalence of pro-
inflammatory cytokines in the PF can have damaging effects on multiple facets of 
female reproduction [Ngo et al. 2009]. Using an animal model, Stilley et al. have 
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shown that PF which bathes the ovary is able to traverse throughout the female 
reproductive tract, moving into the oviducts, past the utero-tubal junction, and 
distally through the uterus and vagina [Stilley et al. 2009].  This suggests that 
reproductive tissues are exposed to the PF in women with endometriosis, 
predictably containing a variety of anomalous endometriotic secretions.  This 
exposure may lead to the numerous difficulties involving fertility.  
 For example, ovulation is reportedly impaired in animal models of 
endometriosis.  One predicted cause of ovarian dysfunction is the presence of 
lesion-produced TIMPs in the thecal cells of antral, pre-ovulatory follicles [Stilley 
et al. 2009].  TIMP1 is a primary contributor, suppressing MMPs 2 and 9, 
inhibiting their gelatinase activity on the basement membrane of the follicle 
[Stilley et al. 2009; Stilley et al. 2010].  In turn, TIMP1 decreases the ovulatory 
potential of a Graafian follicle.  These observations about TIMP1 localization 
positively correlate with the increased number of luteinized unruptured follicles 
(LUFs) observed in a rat model of endometriosis [Stilley et al. 2009].  In this 
same rat model [Stilley et al. 2009], MII-stage oocytes collected from 
endometriosis animals display greater levels of darkened, irregular ooplasm and 
abnormal nuclei compared to those collected from healthy animals.  Abnormal 
pre-implantation embryonic development is also a common occurrence in women 
with endometriosis [Brizek et al. 1995].  The level of blastomere fragmentation 
and the presence of vacuoles, darkened cytoplasm, and uneven cells are 
elevated in embryos collected from women with endometriosis, for example 
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[Pellicer et al. 1995; Brizek et al. 1995].  All of these factors may reduce 
reproductive health.   
There is an increased level of nuclear abnormalities, such as DNA/nuclear 
fragmentation and irregular chromosomal orientation throughout mitosis in these 
embryos [Stilley et al. 2009; Stilley et al. 2010].  A primary explanation is an 
elevated exposure to reactive oxygen species (ROS).  Reactive oxygen species 
lead to DNA strand breaks, inducing the transcription of nucleotidyl-damage 
markers [Laurent et al. 2005].  Dependent upon the severity of the damage, this 
may activate the apoptotic pathway, leading to embryonic cell death [Laurent et 
al. 2005].  
Tumor necrosis factor alpha, another component secreted by ectopic 
lesions into the PC, binds to the tumor necrosis factor receptor (TNFR) on the 
cell membranes of blastomeres [Sheikh and Huang 2003].  This is an alternative 
upregulator of apoptosis, acting through the intracellular tumor necrosis factor 
type 1/Fas associated protein with death domain (TRADD/FADD) pathway 
[Sheikh and Huang 2003].  Both apoptotic triggers lead to the activation of 
caspase-dependent signaling pathways, involved in the degradation of 
components necessary for cellular survival (e.g. DNA and nuclear lamins).  
Blastomeric blebbing, characterized as the decoupling of the cytoskeleton from 
the plasma membrane, is common in apoptotic cells [Mills et al. 1998; Coleman 
et al. 2001].  This event is followed by the formation of distinctive apoptotic 
bodies, characterized as cellular fragmentation in abnormal embryos, a 
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predominant characteristic found in preimplantation embryos collected from 
mothers with endometriosis [Brizek et al. 1995].   
Tissue inhibitor of metalloproteinase 1 is another potential contributor to 
the detrimental phenotypes exhibited in embryos collected from women with 
endometriosis.  It was observed that treating healthy rat zygotes with 
endometriotic concentrations of TIMP1 for 24 hours lead to the development of 
two cell embryos with an increase in nuclear fragmentation, abnormal nuclear 
pore complex distribution, and a reduced potential to process sperm tails [Stilley 
et al. 2010].   
There is also a significant reduction in the presence of antioxidants, such 
as glutathione and superoxide dismutase, observed in a non-human primate 
model of endometriosis [Hastings et al. 2006].  This factor has been observed in 
human studies [Szczepańska et al. 2003].  This is another potential contributing 
factor to the decreased ability of endometriosis patients to mediate tissue and 
embryonic oxidative damage. 
Another cause of subfertility observed in women with endometriosis is a 
reduction in uterine receptivity to the developing embryo, predominantly due to a 
dysregulation of integrins [Apparao et al. 2001; Casals et al. 2012].  Integrins are 
transmembrane receptors that mediate contact between cells.  The integrin αvβ3, 
an important contributor to embryonic-uterine receptivity [Lessey et al. 1994], has 
been observed to be downregulated in the endometrium in endometriosis 
patients [Kim et al. 2007].  One explanation for this decreased integrin 
expression involves homeobox protein A10 (HOXA10).  Homeobox protein A10 
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is a homeobox transcription factor involved in the expression of the β3 subunit of 
the αvβ3 integrin, also known to be downregulated in the eutopic endometrium of 
women with endometriosis [Lessey et al. 1994; Vitiello et al. 2007].  Under 
normal circumstances, HOXA10 peaks during the window of implantation, 
elevating the level of intact, functional αvβ3, allowing for the recognition and 
binding of the conceptus to the uterine lining.   
Homeobox protein A11 (HOXA11) is another downregulated transcription 
factor observed in the endometrium of individuals with endometriosis [Jana et al. 
2013].   Homeobox protein A11 expression is negatively correlated with MMP2 
and MMP9 expression, and positively correlated with the presence of uterine 
pinopodes [Jana et al. 2013].  Increased MMP2 and MMP9 activity leads to an 
elevated level of extracellular matrix (ECM) turnover during the window of 
implantation, while the downregulation of endometrial pinopodes causes a 
reduction in uterine-embryo recognition [Jana et al. 2013].   
Leukemia Inhibiting Factor (LIF), an important regulator of stromal 
decidualization and embryo implantation, is also downregulated in the eutopic 
endometrium of patients with endometriosis [Dimitriadis et al. 2006].  These 
observations strongly suggest a malfunction in uterine receptivity due to 
abnormal expression of important transcription factors.  
Treatments of Endometriosis 
 The most common treatments for endometriosis involve the down 
regulation of sex hormones, anti-inflammatory medications and/or surgery 
[Belaisch 2009; Macer and Taylor 2012].  The hormonal treatments include 
gonadotropin releasing hormone (GnRH) analogs, female contraception, and 
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progestin capsules [Belaisch 2009; Macer and Taylor 2012].  Aromatase 
inhibitors are another potential treatment of this disease that have yet to be 
approved for human use [Langoi et al. 2013].   
In general, hormone treatments are beneficial as they target a reduction in 
estradiol production, a well-characterized sex steroid known to exacerbate the 
development of endometriotic lesions [Benagiano and Brosens 1991].  For 
example, continued administration of progesterone negatively feeds back on the 
anterior pituitary, reducing the production of follicle stimulating hormone (FSH) 
and luteinizing hormone (LH), concomitantly reducing ovarian estrogen 
production.  These same treatments typically lead to the cessation of menses, 
reducing the presence of necrotic menstrual tissue in the peritoneal cavity due to 
a simultaneous reduction in retrograde menstruation [Belaisch 2009; Macer and 
Taylor 2012; Langoi 2013].   
Commonly prescribed in combination with surgery, these treatments have 
been moderately effective when it comes to the alleviation of symptoms 
associated with endometriosis. Yet, even under optimal circumstances, this 
disease frequently recurs, capable of exhibiting a recurrence rate of up to 50% in 
in a five year period [Vercellini et al. 2003]. 
Endometriosis is not curable by any known treatment. Further, treatments 
come at the cost of negative side-effects, varying from patient to patient.  For 
example, many current treatments lead to sterility due to the disruption of sex 
steroid production and subsequent deregulation of folliculogenesis, ovulation, 
and/or pituitary hormone release [Belaisch 2009].  Dependent upon the severity 
12 
 
of the disease, a physician’s recommendation may range from lesion excision 
using a laparoscopic approach to a hysterectomy, followed by combination drug 
therapy [Belaisch 2009].   
Animal Models of Endometriosis 
Validated animal models are important when studying human maladies.  
In the case of endometriosis, the non-human primate is a suitable model 
[Hastings and Fazleabas 2006; Dehoux et al. 2011].  The Rhesus macaque and 
baboon are two species most commonly utilized [Dehoux et al. 2011].  Primates, 
which undergo ~30 day menstrual cycles and exhibit retrograde menstruation, 
are capable of spontaneously developing endometriosis [Story et al. 2004; 
Dehoux et al. 2011].  Data extrapolated from primates is more relevant to human 
disease and medicine than data accumulated from other animal models. There 
are some disadvantages to working with primates.  These include ethical 
limitations associated with both human and non-human primate research, and 
the high cost of animal care and housing [Hastings and Faxleabas 2006; Dehoux 
et al 2011].    
Induced endometriosis in the rodent is an important and frequently used 
model of this disease. A surgical model developed by Vernon and Wilson [1985] 
involves the autotransplantion of uterine tissue into the vasculature of the small 
intestine.  This location mimics the abdominal localization of displaced 
endometrial tissue in women with endometriosis, while nourishing the implants 
with necessities such as oxygen and nutrients.  Over a period of four weeks, the 
implants are allowed to grow and develop in response to the cyclicity of 
reproductive hormones [Vernon and Wilson 1985].   
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The primary advantage of the rat model involves their short reproductive 
cycle, exhibiting 70 to 80 estrous cycles per year and a 20 to 23 day gestation 
period.  These factors allow labs to accumulate a greater amount of data in a 
year compared to other animal models [Vernon and Wilson 1985; Sharpe-Timms 
2002].  Rats are also much less costly to care for and house, along with being 
easier to handle in comparison to non-human primates.  
Another method of imitating endometriosis in rodents includes the injection 
of homogenized eutopic endometrium into the rodent’s abdominal cavity in order 
to simulate retrograde menstruation [Hirata et al. 2005].  Dependent upon the 
species and strain of rodent, some of the endometrial tissue will attach to the 
peritoneum and form lesions, exacerbated by the addition of estradiol [Hirata et 
al. 2005]. 
It has been determined that both the surgical and injection models exhibit 
similar characteristics to those of women with endometriosis, including the 
phenotype of subfertility [Vernon and Wilson 1985; Sharpe-Timms 2001; Story et 
al. 2004].  Established endometriotic implants contribute to the presence of 
inflammatory, anti-apoptotic, and pro-angiogenic/pro-neovascular factors in the 
rat and mouse PF [Story et al. 2004; Sharpe-Timms 2002; Stilley et al. 2009].  
The excess of these factors is predicted, as in humans, to act as a primary cause 
of the reproductive anomalies observed in these models.    
The primary disadvantage of a rodent model is attempting to relate 
collected data to human health and development [Sharpe-Timms 2002].  For 
example, rodents display an estrous cycle, exhibiting endometrial proteolytic 
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breakdown of its extracellular matrix (ECM), followed by subsequent absorption.  
Therefore, in the wild, rats and mice are incapable of naturally developing the 
disease, due to their inability to menstruate.  Even when one considers this fact, 
it is important to remember that advantages of rodent models are still plentiful. 
Fertilization 
Accumulating evidence from a variety of human studies suggests that 
endometriotic secretions disrupt normal sperm-oocyte interactions, contributing 
to female subfertility [Sueldo et al. 1987].  Elevated levels of ROS and free-
floating iron in the PF of endometriosis women could induce lipid peroxidation, 
and possible sperm DNA damage in the female reproductive tract [Allaire et al. 
2006; Aitken et al. 2012].  Spermatozoa also express TNFR on their surfaces, 
capable of binding to the high levels of TNFα located in Endo patient PF, 
potentially leading to high levels of blastomere apoptosis [Mansour et al. 2009].   
Cumulatively, all of these factors may lead to the apoptosis of 
spermatozoa, due to the activation of the enzymatic caspase cascade, 
preventing their interaction with the oocyte.  Alternatively, spermatozoa may be 
severely damaged, reducing their motility and ability to undergo the acrosomal 
reaction.  It has also been observed that sperm-binding to the endosalpinx, the 
mucous membrane lining the interior portion of the fallopian tube, may be 
disrupted in women with endometriosis [Reeve et al. 2005].  Further, attachment 
to the endosalpinx of the oviductal isthmus has been associated with 
spermatozoa capacitation and hyperactivation, two events necessary for oocyte 
penetration.    
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Oviduct Dynamics 
As an embryo continues to develop past the 2 cell (2C) to 4 cell (4C) 
stage, it moves down the oviduct, from the ampulla toward the isthmus.  This 
movement is modulated by a set of carefully regulated mechanisms including 
oviductal cilia dynamics, smooth muscle contractions, and luminal fluid 
composition [Lee and Yeung 2006].  These mechanisms are controlled by 
hormonal influences, primarily progesterone, estrogen, and prostaglandin E and 
their corresponding receptors.  As can be expected, a balanced proportion of 
these hormones is required to temporally and spatially control pre-implantation 
embryo development and migration [Lee and Yeung 2006].  Embryos spend a 
defined period of time in the oviduct prior to uterine implantation, from the zygote 
to 8 cell (8C) stage in both bovine and rodents [Hamilton & Laing 1946], and the 
zygote to 4C or 8C stage in porcine and ovine, respectively [Pomeroy 1955; 
Holst 1974].  The primary reason behind this extended stay is that the oviduct is 
a much more conducive environment for embryonic growth than the uterus 
during the first few days post-fertilization due to the presence of necessary 
metabolites and amino acids.  Table 1.2 shows common uterine and oviductal 
compositions present in a healthy human female [Gardner 2008].   
Considering that estrogen and prostaglandin E2α are two molecules 
known to be elevated in the PF of endometriosis women, it is logical to conclude 
that oviductal dynamics in these same women may be disrupted, subsequently 
reducing the tightly regulated signaling that occurs between the maternal and 
embryonic environment.  Using a baboon model of endometriosis, an association 
between progesterone resistance and the abnormal upregulation of both 
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estrogen receptor 1 (ESR1) and oviductal glycoprotein 1 (OVGP1) (involved in 
sperm:zona pellucida binding and ESR expression) was observed in the oviducts 
of the diseased animals during the window of implantation [Wang et al. 2009].  
These dysregulated components, if similarly present in human oviductal tissue, 
may also contribute to endometriosis-induced subfertility. 
Early Stage Preimplantation Development (One Cell to Morula) 
As early development progresses, there are many events that must 
appropriately occur in order to establish a healthy embryo.  These include 
theregulated expression of Ped, a regulator of cleavage rate, and the totipotency 
genes Oct4, Nanog, and Sox2 [Wang and Dey 2006].  Another event is that of 
the Maternal to Zygotic Transition (MZT).  After fertilization takes place, 
maternally stored transcripts and organelles drive embryonic growth and 
proliferation during the first few cleavage divisions [Wang and Dey 2006].  At a 
certain point, this being species-specific, a large majority of these transcripts and, 
in turn, maternal protein products, are degraded, leaving exclusive control of 
development to the zygotic genome.  The MZT in mice occurs at the 2C stage, 
the 4C stage in pigs, and the 4,000 cell to 8000 cell stage in frogs [Kanka 2003; 
Wang and Dey 2006].  In mice, up to 90% of maternal mRNA is degraded by the 
middle of the second cleavage [Hake and Richter 1997].  It is important to 
mention that transcription of the embryonic genome begins as early as the 
zygotic stage in many different species, but the levels of transcriptional activity 
are extremely minimal [Hake and Richter 1997].   
There are two important categories of maternal mRNA:  1) that which is 
replenished upon activation of the zygotic genome and 2) that which is not 
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subsequently expressed in later stage embryos [Walsch et al. 2011].  In 
reference to the former, these specific transcripts code for a variety of important 
cellular components, ranging from cytoskeletal scaffolding proteins (e.g. tubulin 
and actin) to glucose metabolizing enzyme (e.g. glucose-6-phosphate 
dehydrogenase).  Dysregulation of these important transcripts may lead to an 
abnormal phenotype in the pre-implantation embryo.  A good example involving 
the second category of maternal mRNA would be the regulated expression of c-
mos, a protein present in the mouse oocyte that is important in the timed 
regulation of meiosis and mitosis [Kim et al. 2002].  Delayed degradation of the c-
mos transcript leads to embryonic growth arrest at the MZT in mice [Kim et al. 
2002].  Also, microRNA, involved in epigenetic regulation, is an important 
contributor to the temporal and orchestrated degradation of maternal transcripts 
[Walsch et al. 2011].   
While there have been very few studies performed on the effects of 
endometriosis on the MZT, there have been multiple associations made between 
abnormal pre-implantation embryos and endometriosis.  For example, the 
exposure of 2C stage murine embryos to the PF of women with endometriosis 
leads to increased levels of nuclear fragmentation and blastomere apoptosis, 
reduced developmental potential, and an overall increased level of embryo 
toxicity compared to controls [Tzeng et al. 1994; Gomez-Torre et al. 2002].  
Utilizing microarray technology, Birt found that 8C stage embryos collected from 
rats with surgically induced endometriosis exhibited abnormal expression of 
multiple genes related to apoptosis, cell cycle progression, RNA processing, and 
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oxidative stress responsiveness [Birt et al. 2013].  This data leads to the logical 
conclusion that there may be multiple regulatory gene pathways dysregulated 
throughout early embryo development, potentially reducing the ability of the 
endometriosis embryos to respond to external stressors.    
Later Stage Preimplantation Development (Morula to Blastocyst) 
At approximately the 16 cell (16C) stage in humans, reaching the utero-
tubal junction, an embryo begins to develop into a morula.  The time point of 
morula formation is dependent upon the species.  Up to this point in 
development, the blastomeres of the pre-implantation embryo have been loosely 
connected through microvilli and a low number of gap junctions, allowing 
intercellular communication and small molecule exchange [Watson et al. 2004; 
Eckert and Fleming 1997].  Prior to the morula stage of development, cells begin 
undergoing a calcium-dependent process known as compaction [Watson et al. 
2004]. This is the point and time of development when the embryo goes through 
a physical change that causes its apical surface cells to flatten and form 
connecting tight junctions, while the interior cells maintain increased connections 
due to an upregulation of gap junctions [Watson et al. 2004].  It is interesting to 
note that, even under a high powered microscope, it is impossible to distinguish 
individual cells of a compacted morula.   
This distinctive change in embryonic morphology is associated with 
important developmental events.  First of all, embryos begin to exhibit polarity 
around the time of compaction [Watson et al. 2004; Motosugi 2005; Eckert and 
Fleming 2008].  Polarity allows an embryo to establish and distinguish cellular 
position, leading to the outer, flattened cells to later differentiate into 
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trophectoderm (TE), and the inner cells to maintain their pluripotency and form 
the inner cell mass (ICM).  The second purpose is to aid in embryonic fluid 
accumulation and retention, leading to the formation of an embryonic blastocoel.  
Using a rat model, Stilley made the observation that Endo embryos frequently 
arrest at the 8C stage, or the time point in which healthy rat embryos begin to 
undergo compaction [Stilley et al. 2009].  This shows another potential 
association between endometriosis, abnormal preimplantation development, and 
the inability to undergo compaction.   
The final stage of mammalian pre-implantation embryo development is 
that of blastocyst formation.  Up to this point, all cells of the embryo have been 
considered totipotent.  Blastocysts, on the other hand, are formed from two 
different cell types, as referenced above:  the TE and the ICM.  The TE is 
programmed to differentiate into the extra-embryonic tissue known as the 
placenta, and the ICM is destined to develop into the embryo proper [Watson et 
al. 2004].  While the TE is programmed to become placental tissue, induced 
through the expression of genes such as Tead4 and Cdx2, the ICM maintains a 
pluripotent state due to its continued, upregulated expression of Sox2, Nanog, 
and Oct4  [Watson et al. 2004].  
One of the distinctive features of a blastocyst is that of blastocoel 
formation.  A blastocoel is a fluid-filled cavity that is formed due to the increased 
TE expression of Na+/K+ ion transporters, localized to its basolateral membrane.  
These active transport ion channels form a concentration gradient across the TE 
that leads to inner-embryo water accumulation, facilitated by the up regulation of 
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aquaporin channels [Watson et al. 2004].  Along with acting as a liquid medium 
for a variety of metabolites and molecular building blocks, the blastocoel plays a 
vital role in the process of blastocyst hatching out of the ZP.   
In many mammals, after the ZP-enclosed blastocyst has migrated to the 
upper portion of the uterus, the embryo becomes much more dynamic in 
movement, expanding and contracting against the ZP until it opens up to allow 
for blastocyst hatching [Watson et al. 2004].  Aided by several enzymes, 
including a trypsin-like protease [Watson et al. 2004], the blastocoel plays a 
significant role in reducing the integrity of the ZP.  If the embryo is unable to 
hatch, it is incapable of implantation and further growth.   
One final important purpose of the TE is to prevent a maternal immune 
attack against the ICM [Eckert and Fleming 1997]. This tightly associated cellular 
barrier also reduces the overall level of harmful osmolites that may otherwise 
diffuse into the blastocyst, preventing further damage to the ICM [Eckert and 
Fleming 1997].  Table 1.1 compares the basic requirements of mammalian 
precompaction versus postcompaction embryos.   
Retrospective studies, using in vitro fertilization (IVF) clinical records, have 
shown that blastocysts from women with endometriosis exhibit reduced 
blastomere number and decreased blastomere mitosis rates [Brizek et al 1995; 
Pellicer et al. 1995; Tanbo et al. 1995].  Additional research will be needed to 
elucidate a relationship between endometriosis and blastocyst quality as a 
means of further determining the association between the disease and 
subfertility. 
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Metabolism and Preimplantation Development 
Metabolism plays a very important role in all cell types.  This process aids 
in the production of a variety of substrates necessary for nucleotide formation 
and cellular growth and development.  Metabolism provides cells with energy in 
the form of adenosine triphosphate (ATP), utilized in a variety of cellular 
processes ranging from cell signaling to enzyme activity [Conaghan et al. 1993; 
Bavister 1995].  The body has a tightly regulated group of associated metabolic 
pathways that include glycolysis, pentose phosphate pathway (PPP), and the 
citric acid cycle (CAC).  These pathways are controlled in a way that optimally 
provides the body with what is required at any specific time.  Metabolism is 
equally important in the context of early embryonic development.   
The general dogma suggests that early cleaving embryos from the zygote 
to the morula stage produce the majority of their ATP through oxidative 
phosphorylation [Bavister 1995; Houghton and Leese 2004].  This has been 
observed in mouse, hamster, sheep, cattle, and human [Hillman and Flynn 1980; 
Bavister 1995; Kito et al. 1997; Kanka 2003].  Moderate to high levels of glucose 
are toxic to early cleaving embryos in culture medium [Conaghan et al. 1993; 
Miyoshi et al. 1994].  Elevated glucose may inhibit the transcription of certain 
genes involved in the progression of in vitro embryonic development.  Other in 
vitro studies performed in mice attempt to disprove this idea, showing that the 
early detrimental effects of glucose may be alleviated by the addition of amino 
acids, metal chelators, and/or vitamins [Bavister 1995; Leese 2012].   
Early stage preimplantation embryos of numerous species are more 
inclined to utilize pyruvate and lactate as their primary and immediate energy 
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sources, as opposed to glucose.  Pyruvate is a 3-carbon molecule that can be 
directly shuttled into the mitochondrial citric acid cycle and further broken down to 
produce ATP for the quickly developing early embryo [Conaghan et al. 1993; 
Noordin 2008].  Lactate can be reversibly oxidized to pyruvate, and thereby 
similarly contribute to immediate embryonic energy production.   
Early stage embryos are also considered metabolically quiescent, 
explaining their noticeably high ATP: ADP ratio compared to later stage embryos 
[Houghton and Leese 2004].  It is important to note that all stages of 
preimplantation embryos express membrane glucose transporters, as well 
[Pantaleone and Kaye 1998].  The low levels of early stage glucose taken up by 
these transporters have been shown to be primarily shunted into the pentose 
phosphate pathway (PPP), sustaining stores of reducing molecules necessary for 
other cellular processes.  If the balance of glucose, pyruvate, and lactate is 
dysregulated, the embryos may undergo atresia.  Moderate to high 
concentrations of phosphate have been observed to be detrimental to early 
embryos in a large majority of mammalian species [Miyoshi et al. 1994; Lane and 
Gardner 2007].   
Post morula stage, glucose becomes the preferential energy substrate 
[Houghton and Leese 2004; Leese et al. 2008]. The increase in consumption has 
been attributed to the many essential processes that occur during this latter 
developmental stage, including the initiation of cellular differentiation and 
blastocoel formation. There is also an elevated requirement for ATP in 
blastocysts due to the increased necessity for macromolecular synthesis (e.g. 
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DNA, RNA, and proteins).  While the ICM has been shown to rely completely on 
glycolysis for energy, the TE metabolizes glucose principally through oxidation-
based metabolism [Robinson and Benos 1991; Houghton et al. 2004]. 
 There is a sharp increase in glucose consumption at the blastocyst stage, 
yet it only immediately accounts for ~17% of the total ATP produced [Thompson 
et al. 1996].  The oxidation of pyruvate is still predominant in the fact that it is 
accountable for ~40% of ATP production at this time point [Thompson et al. 
1996].  A logical explanation for this occurrence is that glucose is necessary for 
other purposes in the blastocyst, potentially contributing to the accumulation of 
important glycolytic intermediates such as glucose-6-phosphate and fructose 1, 
6-bisphosphate [Thompson et al. 1996].  Glucose-6-phosphate, for example, may 
be alternatively shuttled into the PPP, where it is involved in replenishing stores 
of nicotinamide adenine dinucleotide phosphate (NADPH), ribulose-5-phosphate, 
and/or nucleotide precursors.   
Similar to oocytes, embryos tend to have a general requirement for fatty 
acid oxidation.  While a majority of culture media are not supplemented with 
lipids, they do include some type of supplemental serum, such as bovine serum 
albumin (BSA).  Bovine serum albumin is a known carrier of fatty acids [Richieri 
et al. 1993] and as such indirectly adds fatty acids to embryo culture media.  As 
stated, specifically at the blastocyst stage, ~57% of ATP production is accounted 
for by glucose and pyruvate metabolism [Thompson et al. 1996].  Fatty acid 
metabolism is predictably the best explanation for the unaccounted 43% of 
embryonic ATP [Yamada et al. 2012].   
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It has been observed that octanoate, a medium-chain fatty acid, can act 
as a fairly efficient energy source throughout the entirety of embryonic 
development [Yamada et al. 2012].  While early stage embryos tend to express 
the enzymes necessary to break down small- and medium-chain fatty acids, 
blastocysts are capable of utilizing small-, medium, and long-chain fatty acids 
[Hillman and Flynn 1980; Yamada et al. 2012].   
It is very easy to disrupt the overall process of embryonic development.  In 
vivo, it takes a distinct spatial and temporal coordination of pH, osmolality, and 
temperature, along with proper metabolite uptake, to supplement embryonic 
growth.  This is why, when designing a successful embryo culture system, it is 
important to mimic this normal in vivo environment [Han and Niwa 2003; Jang et 
al. 2007; Rizos et al. 2008].   
In Vitro and Cell Culture Media Conditions 
The initial observation that mouse embryonic growth could be improved 
when calcium chloride was replaced with calcium lactate triggered an interest in 
culture media optimization in the late 1950s [Whitten 1957].  Around this time, a 
researcher by the name of Whitten observed that mouse embryos could grow 
from the 8C to blastocyst stage in a Krebs-Ringer bicarbonate system, 
supplemented with glucose, bovine plasma albumin, and antibiotics [Whitte 
1957].  These initial studies determined that embryos have different 
developmental requirements from somatic cells, specifically in relation to 
glucose.  Also, Whitten’s studies laid the foundation for future researchers to 
begin optimizing culture media in a variety of different species, attempting to 
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overcome the developmental block that corresponds to the MZT [Brackett et al. 
1982; Miyoshi et al. 1994].   
It is important to mimic the oviductal environment when designing a 
culture media for early embryonic development in vitro.  Along with the variety of 
important proteins and metabolic components produced by the embryo itself, the 
oviduct provides a wide array of growth factors, cytokines, and other 
embryotrophic components that contribute to the normal growth of an embryo 
[Lee and Yeung 2006].  For example, porcine oviducts have been observed to 
secrete at least 14 different proteins when grown in culture, including TIMPs and 
oviduct specific glycoprotein [Stokes et al. 2005].  Additionally, these proteins can 
be differentially expressed dependent upon hormonal influence.  
The oviduct also helps to maintain pH, temperature (~37°C to 40°C, 
depending on the species), and solute concentrations necessary to sustain 
development [Lee and Yeung 2006].  In this respect, most mammalian culture 
systems are buffered accordingly, and in an incubator with an atmosphere of 5% 
CO2 in air.  This percentage may vary, dependent upon the makeup of the 
medium, in order to sustain a consistent physiological pH.  A bicarbonate based 
buffer system is used to provide a stable pH in the presence of high levels of 
CO2, while a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer 
system aids in pH sustainment outside of a CO2 incubator under normal 
environmental conditions [Hentemann et al. 2011].   
The pH and osmolality of an early embryonic microenvironment must stay 
consistent in order to stabilize a growing embryo’s internal conditions, to prevent 
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blastomere lysis and/or apoptosis.  In the oviduct, a variety of non-essential 
amino acids, metabolites, and serum albumin play this significant role [Lee and 
Yeung 2006].  This is especially important in early embryos, due to the fact that 
they maintain a poorly developed ion transporter system and have difficulty 
protecting their internal environment from stress in comparison to post-
compaction embryos [Watson et al. 2004].  Early stage embryos take up less 
oxygen compared to later-stage expanding blastocysts in vivo.  It has been 
documented that, while early stage murine embryos take up ~4 µl/mg of oxygen, 
blastocysts increase consumption by over twice this amount [Thompson et al. 
1996].  In reference to embryo culture, there are many animal studies which 
indicate that high oxygen tension, ranging between 10% and 20%, is detrimental 
to embryos of certain species, while lower, environmental oxygen tension may be 
beneficial [Gardner 2008].   
For example, cattle and rabbits demonstrate optimal embryonic 
developmental potential at an O2 concentration of 5%, while rats and mice thrive 
at much lower concentrations [Fischer and Bavister 1993; Guerin et al. 2001].  
The adverse effects of high oxygen are believed to be due to the production of 
ROS, or molecules that have the ability to induce DNA damage and blastomere 
apoptosis [Yang et al. 1998].  This may be avoided by including antioxidants in 
culture media, such as the tripeptide glutathione; but, this only helps to a certain 
degree [Gardiner et al. 1995].  Glutathione is a nonessential nutrient that is 
considered a reducing agent, capable of decreasing the reactivity of harmful, 
unstable molecules such as free radicals and ROS by acting as a proton donor.  
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Even with this information, researchers have yet to develop optimal in vitro 
human culture media.   As a precautionary measure, IVF clinics may maintain a 
low incubator O2 concentration throughout embryo culture [Burton et al. 2003] . 
Amino acids have important functions in the developing embryo, as well.  
Along with being necessary for protein production, amino acids can act as 
embryonic chelators, anti-oxidants, osmolytes, and metabolic substrates 
[Partridge and Leese 1996; Gardner and Lane 1998].  For example, glutamine, a 
polar, charged amino acid, is beneficial due to the fact that it can be broken down 
into varying components utilized in the citric acid cycle, along with being a 
primary nitrogen source for the embryo.  Glycine is also an important osmotic 
regulator in early stage embryos (Partridge and Leese 1996; Gardner and Lane 
1998].  This is why amino acid supplementation in culture media is extremely 
important.   
Amino acids spontaneously break down in a 37oC culture medium 
environment, producing embryotoxic by-products such as ammonium.  
Glutamine, due to its volatile nature, tends to be responsible for the vast majority 
of the ammonium [Lane et al. 2001].  A stable di-peptide version of glutamine, in 
the form of either alanyl-L-glutamine or glycyl-L-glutamine, is supplemented as a 
replacement [Lane et al. 2001].  Embryonic amino acid profiles can be utilized to 
judge overall quality and developmental potential of embryos cultured in vitro 
[Booth et al. 2007].   
All embryonic stages, from the early cleaving to post-compaction, 
necessitate non-essential amino acids (NEAA) in culture media [Bavister 1995; 
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Gardner 2008].  Essential amino acids (EAA) may be detrimental to early 
cleaving embryos, but required for post-compacted embryo development 
[Gardner and Lane 1993].  There are a few theories that attempt to explain this 
phenomenon.  One example is that early stage embryos, known to have minimal 
control over transmembrane transport may be unable to take up a variety of 
essential amino acids due to a lack of appropriate transporters.  This excessive 
presence of non-metabolized EAAs in the media leads to an increased 
prevalence of toxic products (e.g. ammonium) that would be harmful to the 
embryos (due to increased EAA degradation) [Gardner and Lane 1993].   
Post-compacted embryos maintain a well-established system of Na+/K+ 
pumps, and amino acid transporters capable of controlling their internal 
environment and taking up both EAAs and NEAAs [Watson et al. 2004].  This 
well-developed transport system is why morulaes and blastocysts are less 
sensitive to environmental changes compared to early cleaving embryos.    
There are a wide variety of non-metabolic factors important to in vitro 
culture.  For instance, in order to avoid osmotic dysregulation, media must 
maintain a salt composition (e.g. NaCl and KCl) to maintain osmolality in the 
range of 275 to 290 mOsm [Baltz 2012].  This is especially important in early 
stage embryos, which, as mentioned previously, have difficulty in maintaining a 
stable internal environment.   
There are a variety of molecular transporters that require the presence of 
specific ions in order to function, including chloride and sodium [Van Winkle 
2001].  These ions are obtained through the dissociation of the salts within the 
29 
 
liquid medium.  For example, in mice, glycine transporters, predominant in early 
stage embryos, have been observed to be Cl- and Na+ dependent.  Magnesium, 
frequently present as the stable MgCl in culture media, is another important ion, 
acting as a cofactor in a variety of enzymatic systems involved in embryonic 
growth [Van Winkle 2001].  
 In the past, maternal serum, with a plethora of factors beneficial to both 
somatic cell and embryonic growth, including cytokines and vitamins, was used 
in embryo culture media [Pinyopummintr and Bavister 1991; Lim et al. 1994].  
This type of supplementation has predominantly gone out of practice due to the 
fact that there are many uncharacterized components in serum.  Rather, serum 
albumin or synthetic serum substitutes have replaced it.  Albumin is one of the 
most abundant macromolecules located within the oviduct [Lippes et al. 1972; 
Gardner 2008].  It has benefits ranging from the negation of increased colloidal 
osmotic pressure in the embryo to inducing an increase in the surface tension of 
culture media.  The latter effect greatly aids in embryo manipulation.  Finally, 
commercially developed albumin is free from specific types of biological 
contamination, including HIV particles, lending it to be safer to use in human 
embryo culture [Desai et al. 1996].  The above discoveries came about thanks to 
well controlled experiments performed over the last 60+ years.  Culture media 
optimization is still of great interest in research laboratories.  As of yet, there is no 
perfect in vitro medium for any species.  Along with composition, there is the 
importance of general culture system design [Bavister 1995; Vutyavanich et al. 
2011].   
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Some researchers place embryos in small microdrops of medium, while 
others prefer to use a one milliliter volume of medium in double-well culture 
plates.  In either case, it is extremely important to use materials that are non-
embryotoxic [Bavister 1995; Rizos et al. 2008].  There have been observed 
benefits of group culture versus individual culture [Vutyavanich et al. 2011; 
Menezo et al. 2012].  Studies suggest that group culture may be preferential due 
to the release of paracrine factors beneficially effecting adjacent embryos.   
Group culture maintains elevated levels of embryotoxic metabolites when 
compared to individual culture increasing the frequency of necessary media 
culture change.  Group vs. single culture tends to be more of a personal 
preference based on individual researcher observations.  It is also always 
recommended to cover media with light mineral oil to allow for it to equilibrate its 
pH, osmolality, and temperature overnight in a CO2 incubator prior to performing 
experiments [Bavister 1995; Vutyavanich et al. 2011].  Supplementation of media 
with antibiotics is also important, in order to reduce bacterial contamination of the 
culture medium. 
Media may be of a single or sequential type.  Single culture includes a 
single set of components that successfully nourishes the embryo from the zygote 
to blastocyst stage [Reed et al. 2009; Paternot et al. 2010].  The rationale behind 
using a sequential system is that it takes into consideration the changing 
environment of the oviduct, and uterus, as an in vivo embryo travels down the 
reproductive tract.  The elements addressed above (e.g. amino acids and 
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carbohydrates) are included in both types of media at variable concentrations 
[Reed et al. 2009; Paternot et al. 2010].   
Rat embryos, for example, are grown optimally using a sequential media 
protocol [Miyoshi et al. 1997; Miyoshi et al. 1998].  An early stage growth medium 
is maintained at a higher osmolarity than the later stage medium, as a means of 
more stably controlling amino acid and metabolite uptake in the pre-compact rat 
embryos that are more susceptible to external stress [Miyoshi et al. 1998].  The 
sequential version of the rat culture media reportedly leads to a 75% blastocyst 
developmental success rate [John Critser, unpublished]. 
There are a variety of human media, both of the monoculture and 
sequential culture categories [Gardner and Lane 1998; Sepulveda et al. 2009]. 
There have been many studies performed, with predominant use of the mouse 
model, that attempt to determine the differences in these media types.  A meta-
analysis performed on a variety of murine studies has shown that sequential 
media is more beneficial at producing a greater quality of blastocyst, maintaining 
a statistically higher number of ICM and TE cells compared to those grown in a 
single medium [Lane and Gardner 2007].   
These same blastocysts also tend to exhibit higher implantation rates 
when compared to single culture grown embryos.  The G-1™(VitroLife AB, 
Göteborg, Sweden) and G-2™ (VitroLife AB, Göteborg, Sweden) media is an 
example of an industry-produced human sequential system.  The differences in 
G-1 and G-2 are the concentrations of pyruvate, lactate, and glucose (Table  2.1) 
[Gardner and Lane 1998].  
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Preimplantation 1 ® (early stage) and Multiblast® (later stage) (Irvine 
Scientific, Santa Ana, California) is another example of a human sequential 
system. Multiblast® contains glucose and essential/non-essential amino acids, 
while P1® does not. Global® medium (LifeGlobal, Guilford, Connecticut, USA) is 
an example of an industry-produced single culture system.  In vitro fertilization 
clinics throughout the United States use varied embryo culture media, including 
P1®_Multiblast® and Global®.  This choice is primarily dependent upon embryo 
development in each laboratory, taking into consideration available data from 
research studies.      
Murine embryo assays (MEAs) are a common protocol used IVF clinics to 
validate the quality of human embryo culture media [Fleetham et al. 1993; van 
den Bergh et al. 1996].   Murine embryo assays are also used to perform quality 
control studies to ensure the safety of petri dishes, mineral oil, incubators and air 
systems used in each specific IVF clinic to mitigate embryotoxicity [Fleetham et 
al. 1993].  Due to ethical restrictions, human embryos cannot be used in quality 
control protocols.   
The MEA involves the process of growing murine embryos from the pre-
compaction to blastocyst stage, in culture media developed for human embryos.  
The one-cell MEA is recorded as being the most appropriate embryotoxicity 
assay in IVF clinics.  The lack of IVF clinical standardization is due to the fact that 
there is no definitive consensus in the medical community about an optimal 
process that should be used to test embryotoxicity.  Many IVF clinics perform 
MEAs on a monthly or bi-monthly basis.  Production companies also use MEAs 
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as a means of testing the quality of each lot of their media products prior to 
distributing them to laboratories. 
The percentage of blastocyst formation is the most common endpoint for a 
MEA [Fleetham et al. 1993; van den Bergh et al. 1996; Gardner et al. 2005].  
There has been a recent focus on determining alternative endpoints of MEA 
analysis. For example, there have been studies performed looking at the effects 
of toxic volatile compounds, such as formaldehyde, on embryonic amino acid 
turnover (e.g. leucine) in an MEA and its association with embryo quality [Gada 
et al. 2012].  The degree of inner cell mass outgrowth on a gelatin-covered plate 
has also been shown to be correlated with different levels of formaldehyde 
exposure, potentially relating to blastocyst development in media of variable 
qualities [Gada et al. 2012].   It is important to mention that these two types of 
protocols have yet to be utilized in a human IVF environment.   
Different types of endpoints, such as amino acid metabolism and ICM 
outgrowth assays, are of increasing interest because there is a significant 
amount of existing literature that disagrees with the association between current 
MEA results and human IVF [van den Bergh et al. 1996]. More sensitive types of 
quality control are needed as a means of optimizing media.  One idea is that a 
basic MEA should be performed, in adjunct with other quality control protocols.   
Ubiquitin-Proteasome System 
The 26S proteasome, a multi-protein holoenzyme, is a primary example of 
how cellular processes are tightly regulated.  Proteasomal degradation involves 
the targeting and degradation of specifically marked proteins and short-chain 
peptides [Driscoll 1994; Tipler et al. 1997].  A typical mammalian 26S 
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proteasome is made up of two types of complexes:  a 20S proteolytic core, and a 
19S regulatory cap.  The recognition element in proteasomeal proteolysis is an 
8.5 kDa protein known as ubiquitin.  The 19S complex is capable of recognizing 
and binding to chains of ubiquitin that have been linked together through covalent 
bonds, and attached to a targeted protein [Driscoll 1994; Tipler et al. 1997].  
Once the recognition event takes place, the ubiquitin chain is removed, and the 
target substrate is transported into the 20S core where its peptide bonds are 
proteolytically cleaved. 
There are many important temporal and spatial cues that trigger 
proteasomal degradation due to the variety of pathways that are regulated by this 
process.  These include the following:  cell cycle progression and division, DNA 
transcription and repair, apoptosis, meiotic resumption, and the modulated 
response to cellular stressors [Driscoll 1994; Tipler et al. 1997; Dawson et al. 
1997].  Without proper regulation maintained by the ubiquitin-proteasome 
system, cellular function and proliferative ability would be completely 
deregulated, and severe damage to both the designated cell and surrounding 
cells may occur [Driscoll 1994; Dawson et al. 1997].   
The 20S protealytic core is a barrel-shaped structure made up of two beta 
rings flanked on each end by two alpha rings, each ring composed of seven 
subunits  [Dawson et al. 1997].  The core beta rings contain proteolytic enzymes 
that have chymotrypsin-like, trypsin-like, and postglutamyl peptide hydrolyzing 
activities that function in the degradation of target proteins.  The alpha ring is 
strictly involved in modulating the entrance of proteins/peptides into the beta ring 
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core [Dawson et al. 1997; Hendil et al. 1998].  The 19S cap is also formed from 
two distinctive groups of subunits:  the ‘base’ and the ‘lid’.   The base and lid are 
further broken down into two different types of subunits, based on whether their 
activity is either ATP dependent or ATP-independent.  The ATP-independent 
components of the ‘base’ are involved in the recognition and binding of 
polyubiquitin-tagged proteins, while the ATP-dependent subunits are involved in 
protein unfolding and controlled entrance into the 20S portion of the proteasome 
[Dawson et al. 1997; Hendil et al. 1998].  It is important to note that, prior to 
entrance into the proteasomal core, the branching ubiquitin chains are cleaved 
off by a group of proteasomal subunit proteins known as de-ubiquitinating 
enzymes (DUBs) [Zhu et al. 1996; D’Andrea and Pellman 1998].  It has been 
hypothesized that these DUBs are targeted to the active proteasome through the 
non-ATPase subunits of both the 19S base and lid [Hendil et al. 1998].  It is 
important to note that not all DUBs are involved in substrate-ubiquitin cleavage.  
Cellular processes regulated by DUBs can range from subcellular localization to 
protein activation/inactivation [Chung and Baek 1999].   
 There are three components that are of primary importance in the context 
of the ubiquitin-proteasome system.  These include the proteasome itself, the 
DUBs, and the targeting protein molecule(s) known as ubiquitin (Ub).  Ubiquitin is 
a 76-amino acid protein that is conjugated to specific proteins in the form of 
polyubiquitin chains [Dawson et al. 1997].   While targeted protein degradation is 
an important role of ubiquitin binding, it is not the sole purpose of this type of 
molecule.  Ubiquitin can also bind as monoubiquitin to histones, acting as an 
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epigenetic transcriptional regulator, or other cytoplasmic and nuclear proteins, 
aiding in controlled subcellular localization [Wang et al. 2004].  For example, 
mono-ubiquitin has been observed to interact frequently with the histone variant 
H2A at Lys119, regulating chromatin availability for transcription [Baarends et al. 
1999; Wang et al. 2004].  
 It is important to understand the mechanisms behind ubiquitin activation 
and conjugation in order to comprehend just how tightly the ubiquitin proteasome 
system is regulated.  This process involves three different types of enzymes:   
Ubiquitin-activating enzyme (E1), Ub-conjugating enzyme (E2), and a Ub-ligase 
(E3) [Ciechanover 2003].   The enzyme E1 is an ATP-dependent enzyme that 
functions in the activation of ubiquitin through Ub acetylation.  This event leads to 
the formation of a thioester bond between ubiquitin and a cysteine residue 
located in the E1 active site. This E1:Ub complex interacts with and subsequently 
transfers the Ub onto an E2 enzyme [Ciechanover 2003].  Next, E2 interacts with 
a type of ligation enzyme known as E3.  This E2:E3:Ub multiprotein complex will, 
in turn, recognize the product that is to be targeted for ubiquitination, and E3 will 
ligate the Ub molecule onto a designated lysine residue of the substrate 
[Ciechanover 2003].  Further rounds of ubiquitination occur, forming a 
polyubiquitin chain on the targeted peptide/protein, mediated by the ‘E3-like 
protein’ E4.  This chain is then recognized by the proteasomal 19S complex, 
triggering polypeptide degradation.  These Ub chains can occur in a variety of 
branching conformations, leading to varying levels of proteasomal recognition 
[Ciechanover 2003]. The primary structure of ubiquitin is conserved across a 
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wide array of eukaryotic species, exhibiting 96% sequence homology between 
humans and yeast [Ciechanover 2003; Zheng et al. 2009]. 
 Deubiquitinating enzymes are the final type of regulatory component 
involved in the proteasomal-ubiquitin pathway [D’Andrea and Pellman 1998].  
Deubiquitinating enzymes are proteases that target the isopeptide bonds that are 
formed between either two Ub molecules, or a Ub molecule and a targeted 
substrate.  Commonly, this targeted region is the bond formed between a 
substrate’s lysine residue, and the C-terminal carboxylate group of ubiquitin 
[D’Andrea and Pellman 1998].  Deubiquitinating enzymes primarily aid in the 
disassembly of polyubiquitin chains prior to insertion into the 20S proteolytic 
proteasomal core, along with salvaging proteins that had been incorrectly 
targeted for degradation [D’Andrea and Pellman 1998].  In an indirect manner, 
these deubiquitinating enzymes are important in preventing the inappropriate 
regulation of a variety of cellular processes, including cell cycle progression and 
the response to stressors such as reactive oxidative species (ROS).   
In the last 10 years, researchers have begun to speculate on alternative 
‘proteolytic regulatory mechanisms’ of DUBs.  The primary model of interest 
involves the idea that DUBs may bind directly to the E3 ligase enzyme, inhibiting 
its ability to perform the final step of ubiquitination [Sowa et al. 2009]. Numerous 
DUB/E3 binding pairs exist.  It has been stated that this type of pairing may act in 
one or two different ways:  (1) the DUB deubiquitinates E3 before it is able to 
transfer the Ub molecule to the targeted substrate or (2) the DUB destabilizes the 
E2:E3:Ub complex, reducing its functionality [Sowa et al. 2009].  From the 
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literature, it can be interpreted that the core role of DUBs is to regulate the 
attachment and presence of ubiquitin, whether it be in a direct or indirect manner.  
Upon disassembly of ubiquitin chains from the targeted substrates, 
monoubiquitin molecules are regenerated and capable of being recycled for 
further protein tagging [D’Andrea and Pellman 1998; Ciechanover 2003].    
 Similar to the ubiquitinating enzymes, there are multiple classes of DUBs 
[Chung and Baek 1999].  Two primary categories include cysteine proteases, 
and metalloproteinases.  Metalloproteinase DUBs contain active sites that 
require zinc binding in order to maintain activity [Chung and Baek 1999].  
Alternatively, cysteine protease DUBs, also known as thiol proteases, do not 
require the binding of metal ions for activity, and have a specific catalytic 
mechanism that is involved in cleaving protein-protein bonds [Chung and Baek 
1999].   
 There are four known families of cysteine proteases, which are defined 
primarily by the manner in which they interact with Ub molecules.  Two examples 
include the ubiquitin C-terminal hydrolases (UCHs) and ubiquitin specific 
proteases (USPs) [Chung and Baek 1999].  Ubiquitin C-terminal hydrolases may 
either directly bind to and increase the half-life of monoubiquitin, or trim Ub off at 
the distal ends of polyubiquitin chains. In contrast, USPs bind to non-ubiquitin 
tagged regions of a Ub-targeted substrate prior to Ub cleavage and removal.  In 
reference to cysteine protease activity, it seems that the majority of these 
enzymes use a mechanism that involves an important catalytic triad of amino 
acids made up of cysteine, histidine, and aspartic acid/asparagine.  Each specific 
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amino acid plays a role in the protealytic cleavage of ubiquitin [Chung and Baek 
1999].  Interestingly, while it had been previously thought that ubiquitin pools stay 
constant, it has now been shown that this protein can either be degraded by the 
proteasome, or upregulated in expression, dependent upon specific cellular 
conditions [Proctor et al. 2010]. 
There is a subset of cysteine protease DUB enzymes which contain a 230 
amino acid catalytic UCH domain at their N-Terminus.  In humans, there are four 
UCH DUBs that have been identified, including UCHL1, UCHL3, UCHL5, and 
BRCA1 associated protein-1 (BAP1).  Ubiquitin C-Terminal Hydrolase L1 and 
UCHL3 are the smaller of the UCHs, made up entirely of the UCH domain 
[Larsen et al. 1998].  These two enzymes preferentially bind to small proteins that 
have been ubiquitin-tagged.  Interestingly, neither UCHL1 nor UCHL3 is capable 
of cleaving Ub-Ub bonds.  In contrast, BAP1 and UCHL5 have extended strings 
of amino acids adjacent to their UCH domains (~500 and ~100 residues, 
respectively) along with preferentially cleaving Ub-Ub bonds [Larsen et al. 1998; 
Chung and Baek 1999].    
 Ubiquitin C-Terminal Hydrolase L1 and UCHL3 are extremely interesting 
molecules in reproductive physiology, primarily due to their varied expression 
patterns and localization in developing gametes and embryos [Yi et al. 2007; 
Mtango et al. 2012].  It has been observed that UCHL1 is selectively expressed 
in neuronal tissue, gametes, and preimplantation embryos [Yi et al. 2007; Mtango 
et al. 2012].  Ubiquitin C-Terminal Hydrolase L3 is ubiquitously expressed in all 
known types of tissues.  While both of these DUBs maintain 52% homology, their 
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enzymatic activity differs when tested in vitro [Boudreax et al. 2010].  The activity 
of UCHL3 is known to be >200x higher than UCHL1.  Using gad mutant, or 
UCHL1 deficient, and Uchl3 knockout mice, the importance of each of these 
Ubiquitin C-Terminal Hydrolases have also been elucidated in the context of 
fertility and organismal survival.  For example, UCHL1 has been shown to be 
predominantly present in dividing spermatogonia, but not in meiotically maturing 
spermatocytes [Kwon et al. 2005].  Ubiquitin C-Terminal Hydrolase L3, on the 
other hand, is present at all stages of spermatogenesis.  This implies that UCHL1 
is primarily important in the control of the mitotic proliferation of spermatogonia, 
and UCHL3 may be involved in meiotic sperm development and differentiation 
[Kwon et al. 2005].  
The DUBs and the ubiquitin-proteasome system are involved in the 
mediation of cell apoptosis.  The gad mutant mice deficient in UCHL1 exhibited 
an elevated expression of the antiapoptotic proteins Bcl-2 and Bcl-xL, along with 
a reciprocal increase in the prosurvival proteins known as p cAMP response 
element-binding protein (pCREB) and brain-derived neurotrophic factor (BDNF), 
when cryporchid injury was induced [Kwon et al. 2004].  Under normal 
circumstances, this type of injury would have led to an increase in activity of the 
apoptotic pathway, not a decrease.  From this, it is inferred that UCHL1 is 
involved in balancing levels of pro-apoptotic and anti-apoptotic gene products 
[Kwon et al. 2004].  Ubiquitin C-Terminal Hydrolase L1 loss, which is normally 
responsible for binding to and maintaining stable monoubiquitin, may lead to a 
41 
 
reduction in freely available Ub, reducing the overall capability of the cell to 
sustain the appropriate levels of proteasome-targeting polyubiquitin chains. 
In the male reproductive system, it has been observed that UCHL1 and 
UCHL3 maintain distinctive expression patterns throughout the epididymis [Kwon 
et al. 2005].  Ubiquitin C-Terminal Hydrolase L1, for instance, is expressed at a 
higher level in the caput epididymis, while UCHL3 is more highly expressed in 
the cauda epididymis [Kwon et al. 2005; Baska et al. 2008].  It is interesting to 
note that ubiquitin is expressed throughout the epididymus similarly to UCHL1, 
being more highly present in the caput compared to the cauda.  This seems 
logical considering the Ub stabilization function of UCHL1.  From this 
observation, it is tempting to suggest that the high levels of monoubiquitin and 
UCHL1 at the caput contributes to the increased level of apoptosis present in this 
epididymal region, aiding in the elimination of abnormal sperm [Baska et al. 
2008].  This theory is supported by the fact that levels of p53 and Bax, two pro-
apoptotic proteins, are greater in the caput compared to either the epididymal 
cauda or corpus.  Along with being involved in the mediation of male 
gametogenesis, UCHs have been proven to play an important role in sperm 
capacitation and acrosomal exocytosis [Zimmerman and Sutovsky 2009].   
The UCHs also play a key responsibility in female reproductive function as 
well, ranging from the progression of oogenesis to the ‘block to polyspermy’ [Yi et 
al. 2007; Mtango et al. 2012].  Ubiquitin C-Terminal Hydrolase L1 accumulates in 
the cortex of the oocyte.  The cortex includes the plasma membrane and the 
portion of cytoplasm directly adjacent to it; the thickness ranging from 0.1-20 
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micrometers dependent upon species [Sardet et al. 2002].  This section of a cell 
is considered a scaffold for multiple types of components, including groupings of 
endoplasmic reticulum, mitochondria, microtubules/microfilaments/intermediate 
filaments, and a variety of signaling molecules and mRNA.  The proportion of 
what is located in the cortex is dependent upon the species, and the specific 
stage of embryo development [Sardet et al. 2002].  As UCHL1 is tethered to the 
cortical cytoskeleton, it may be involved in important processes regulating oocyte 
maturation, fertilization, and preimplantation development. 
It has been observed that UCHL1 contributes to polyspermy block [Yi et 
al. 2007] .  There have been studies performed that show that the block to 
polyspermy occurs through the regulation of cortical granule (CG) reorganization 
throughout the cortex.  In the mutant gad mice deficient in UCHL1, it is noticeable 
that CG exocytosis is delayed upon sperm-zona pellucida (ZP) penetration [Yi et 
al. 2007].  This delays the subsequent hardening of the ZP, allowing for the 
entrance of multiple spermatozoa into the perivitelline space.  In a large majority 
of species, including rodent, bovine, and human, polyspermy is detrimental to the 
developing zygote [Sun 2003].   
Several factors contribute to the abnormal release of cortical granules in 
fertilized oocytes upon the knockout of UCHL1.  An increased accumulation of 
misfolded proteins has been observed in the endoplasmic reticulum (ER) of gad 
mouse oocytes [Koyanagi et al. 2012]. This is accompanied by the abnormal 
increase of a few different maternally derived proteins, one example being 
maternal antigen that embryos require (MATER).  Based on this study, it seems 
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that one primary role of UCHL1 is to regulate the turnover of specific maternally-
derived proteins, and misfolded polypeptides [Koyanagi et al. 2012].  The 
accumulation of MATER in the cortex of the oocyte has been previously 
associated with oocyte maturation failure.  This resultant lack of oocyte 
maturation, in turn, may lead to delayed ER accumulation in the cortex, reducing 
the overall level of cortical calcium availability.  Calcium release is extremely 
important in the context of cortical granule exocytosis.  The excess of unfolded 
proteins in the endoplasmic reticulum causes ER stress, as can be observed by 
the increased expression of heat shock protein A5 (HSPA5), Endoplasmin 
(ENPL), and Calreticulin (CALR), three chaperone proteins involved in 
moderating ER stress [Koyanagi et al. 2012].  Similar to the excessive presence 
of MATER, this elevated level of ER stress can lead to a subsequent decrease in 
calcium release.   
Mtango et al has shown that both Uchl1 and Uchl3 are expressed 
predominantly as maternal transcripts throughout oogenesis, and are steadily 
reduced in expression upon fertilization and throughout preimplantation 
development [Mtango and Latham 2007].  These results were consistent in both 
mice and Rhesus monkeys [Mtango et al. 2007].  The UCHL1 protein is localized 
to the cortex of both the oocyte and embryonic blastomeres in the mouse 
[Mtango et al. 2012].  Ubiquitin C-Terminal Hydrolase L3 accumulates in the 
oocyte spindle and blastomere nuclei during oocyte maturation and embryonic 
development, respectively.  This has been observed in a variety of species, 
including bovine, porcine, primate, and murine.  Further, in order to further 
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elucidate the functions of UCHL1 and UCHL3, in vitro experiments were 
performed in which oocytes were injected with either an UCHL1 inhibitor, UCHL3 
inhibitor, or an overall UCH inhibitor known as UBAL [Mtango et al. 2012].  
Inhibiting UCHL3 led to abnormal spindle microtubule length and configuration, 
leading them to hypothesize that UCHL3 plays a role in microtubule spindle pole 
focusing, and chromosomal organization and segregation.  Ubiquitin C-Terminal 
Hydrolase L1 and UBAL inhibitor injections led to the extrusion of an abnormally 
large first polar body and abnormal distribution of cortical granules [Mtango et al. 
2012].  Thus, along with maintaining cortical ER calcium release, UCHL1 may 
also be involved in controlling the dynamics of microtubules and microfilaments, 
aiding in the actual allocation of CGs.   
One final interesting note concerning oocytes and the localization of 
UCHL1 and UCHL3, is that UCHL3 may be partially compensatory for UCHL1 
[Mtango et al. 2012].  It was recognized that, in the mutant gad mice deficient in 
UCHL1, UCHL3 localized at the cortex of mature oocytes, along with displaying a 
typical association with spindle microtubules and nuclei.  In oocytes from wild 
type mice, this association does not occur.  Considering that mutant gad oocytes 
are prone to polyspermy and embryonic arrest, it is difficult to interpret the 
importance of this UCHL3 cortical translocation/’replacement’ in these mutant 
gad mice deficient in UCHL1.   
It has also been observed in UCHL1-deficient gad mice that the majority of 
collected embryos were incapable of developing past the morula stage [Mtango 
et al. 2012].  These morulas were suspended in growth around the time of 
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compaction.  Mtango et al also reported that gad mice have 3.6 pups per litter, as 
opposed to the 7.3 pups per litter present from wild type mice [Mtango et al 
2012].  These observations demonstrate that even though UCHL1 deficient 
oocytes are capable of being fertilized, they tend to have reduced developmental 
potential.  More research needs to be done in order to determine why UCHL1 
and/or UCHL3 are required for later stage preimplantation development.     
Project Goals 
Endometriosis is a common disorder associated with female infertility.  
The goal of this project was to determine if zygotes from rats with surgically 
induced endometriosis may be salvaged by removing them from the 
inflammatory environment of the Endo reproductive tract, placing them into an 
established culture system and growing them to either Day 2 or Day 4.  This in 
vitro culture regimen was designed to reduce embryo exposure to harmful 
endometriotic secretions present in vivo.   The outcomes of our research may 
relate to human in vitro fertilization and IVF protocols, specifically referring to 
patients who have endometriosis.  
 A secondary goal of my research was to compare the developmental 
potential of healthy murine zygotes in a sequential media system versus a single 
medium system.  Based on previous observations, our expected outcome was 
that one medium will be superior over the other in supplementing murine 
embryonic growth, which can predictably be associated with the culture of human 
embryos.  It is important to determine which embryo culture protocol most 
successfully supplements human embryo growth and development in vitro, in 
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order to help increase the pregnancy and birth rates associated with subsequent 
embryo transfer performed at IVF clinics. 
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Precompaction Stage 
 
 
  
Postcompaction Stage 
 
   
Low biosynthetic activity 
 
  
High biosynthetic activity 
   
 
Low QO2 (Metabolic Quotient) 
 
 
 
High QO2 ( Metabolic Quotient) 
 
 
Pyruvate-based metabolism 
  
Glucose-based metabolism 
 
Maternal  genome 
 
   
Embryonic   genome  
 
 
 
Low ability to maintain  
cellular homeostasis 
 
   
 
Transport epithelium to maintain 
cellular homeostasis 
Table 1.1: Precompaction Versus Postcompaction Mammalian Embryo Requirements
1
 
1 
Modified from [Lane and Gardner 2007] 
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    Pyruvate (mM) Lactate (mM) Glucose (mM) 
Oviduct   0.32 10.5 0.5 
G-1 (cleavage 
stage) 0.32 10.5 0.5 
Uterus   0.1 5.87 3.15 
G-2 (blastocyst 
stage) 0.1 5.87 3.15 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
Table 1.2:  Media Component Comparison in Humans1 
1 
Modified from [Gardner 2008]  
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Figure 1.1: Ubiquitin-Proteasome System.  A depiction of proteasomal 
protein degradation by the 26S Proteasome, involving the Ub-
activating/conjugating enzymes E1, E2, and E3 as a means of conjugating 
ubiquitin onto a specific proteinaceous substrate [Ciechanover 2003].  
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CHAPTER 2 
 
 
 
 
PREIMPLANTATION EMBRYONIC DEVELOPMENT OF 
RAT ZYGOTES TRANSFERRED FROM AN IN VIVO 
ENDOMETRIOTIC ENVIRONMENT TO AN IN VITRO 
CULTURE SYSTEM 
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INTRODUCTION 
 
 Subfertility is a primary symptom associated with endometriosis, a 
gynecological disorder that afflicts millions of women worldwide [Garrido et al. 
2002].  Known to traverse the lumen of the entire reproductive tract while present 
in peritoneal fluid (PF), endometriotic lesion secretions (e.g. pro-inflammatory 
factors) localize in the thecal cells of the ovary [Stilley et al. 2009].  Furthermore, 
developing embryos are exposed to these same adverse secretions.  Embryos 
obtained from women diagnosed with endometriosis exhibit elevated levels of 
blastomeric fragmentation and developmental arrest [Brizek et al. 1995; Pellicer 
et al. 1995; Yanushpolsky et al. 1998].  Early stage murine embryos are also 
negatively affected when exposed to the PF of endometriosis women [Gomez-
Torres et al. 2002].  While a variety of genes and proteins have been shown to 
be dysregulated in preimplantation embryos collected from rats with surgically-
induced endometriosis, a definitive cause of the aforementioned embryo 
anomalies has yet to be determined [Stilley et al. 2012; Birt et al. 2013].   
It would be beneficial to know at what stage of embryo development 
endometriosis has the most predominant effect.  This would subsequently aid 
researchers and clinicians in narrowing their focus when studying the origin of 
endometriosis-associated subfertility.  Based on this idea, a hypothesis was 
formulated:  utilizing a rat model for endometriosis, Endo embryos, or embryos 
collected from these same rats, may be salvaged by removing them from their 
mothers at the zygote stage and placing them into a defined in vitro environment.  
Numerous women who experience endometriosis-associated subfertility seek the 
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aid of IVF clinics in an attempt to become pregnant.  The implications behind our 
study thus relate to human in vitro fertilization and IVF clinical protocols.  Our 
experiments will help further characterize advantages and/or disadvantages of 
removing embryos from women with endometriosis and placing them into culture 
medium.   
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MATERIALS AND METHODS 
 
Rat Husbandry 
 Sexually mature female Sprague Dawley rats (Harlan, Indianapolis, 
Indiana, USA) of ~225 to 250 grams and ~70 days of age were placed into 
cages, two rats per cage, in a dedicated room in the University of Missouri (MU) 
Medical School vivarium.  The room was maintained at a consistent humidity and 
temperature, following a light:dark cycle of 14 hours:10 hours.  One hundred watt 
incandescent bulbs were used in the room.  The primary purpose behind this 
light/dark cycle was so that the Sprague Dawley rats maintained a regular 
estrous cycle.  The rats were housed and experiments were conducted in 
accordance with The University of Missouri Institutional Animal Care and Use 
Committee (ACUC) Rules and Regulations, in accordance with the National 
Research Council's guidelines. 
A two week acclimation period was allocated prior to initiating experiments 
to reduce post-travel anxiety and familiarize the rats to their new living 
environment. During the first week, human contact was minimized to reduce the 
external stressor of human manipulation.  During the second week, the rats were 
carefully handled at the same time each day, by the same person, to allow 
recognition by the animals.     
Toward the end of the second week, daily vaginal lavage was performed 
between 9 and 10 a.m. and the cytology evaluated microscopically as an indirect 
indicator of reproductive cyclicity.  The lavage was performed using a sterile 
glass pipette. Approximately 200 µl volume of sterile phosphate buffered saline 
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(PBS) containing 1 μg/ml penicillin and 1 μg/ml streptomycin was aspirated into 
the pipet.  The blunted, flat, open end of the pipette was then placed 1-1.5 cm 
into the vagina, where the PBS was gently pipetted two or three times to remove 
cells from the vagina.  The PBS, containing vaginal cells, was expelled onto a 
microscope slide and the cells were observed under a Leica DMLB light 
microscope (200X, Leica, Buffalo Grove, IL, USA) to determine the predominant 
cell type, which in turn, was used to predict the specific stage of each rat’s 
estrous cycle.  The cycle stages were distinguished as described in Table 2.1.   
Endometriosis and Sham Surgeries  
The endometriosis surgical model used in this research was developed by 
Vernon and Wilson (1985). Rats were anesthetized using isofluorane (VetOne, 
Meridian, Idaho, USA) and a unilateral ovariohysterectomy was performed via a 
ventral midline incision. Silk sutures (4-0, Ethicon, Somerville, New Jersey, USA) 
were used to ligate above the ovary and approximately 2/3 of the uterine horn. 
The uterine horn was sectioned down its longitudinal axis with small surgical 
scissors, cut into six equal size 2 x 2 mm pieces.  Using non-absorbable 4-0 
monofilament nylon suture (Ethicon, San Lorenzo, Puerto Rico), the pieces were 
sutured onto the vasculature of the rat’s small intestine.  Immediately after the 
uterine implants had been sutured in place, 1 mL of the sterile PBS with penicillin 
and streptomycin was instilled into the abdominal cavity to hydrate and help 
prevent adhesive disease. The abdominal incision was closed using continuous, 
interlocking absorbable suture (4-0, CPMedical, Portland, Oregon, USA). The 
skin was closed using four to six AutoClip® Wound Clips (9 mm, Becton 
Dickinson, Sparks, Maryland, USA).   There were two control groups for this 
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project, including a sham surgery where one ovary and uterine horn were 
removed but no tissue was sutured into the peritoneal mesentery (Sham rats) as 
well as no-surgery controls (Control rats) (Table 2.2). 
The analgesic Flunixin meglumine (2.5 mg/mL; Prevail, Dallas, Texas, 
USA) was injected subcutaneously at 0.1 mL per gram of body weight to relieve 
any potential pain.  The rats were subsequently monitored post-operatively at 
approximately 30 minute intervals for four hours to assure that they were sternal 
and healthy.  The following morning, the health status was evaluated and the rats 
were injected with a second identical dose of Flunixin meglumine.  For the next 
four weeks, the rats were permitted time to recover from surgery and, in the Endo 
group, let the endometrial implants grow and develop in response to the cycling 
rats’ hormonal milieu.  Beginning one week after the surgeries, daily evaluation 
by vaginal cytology was reinstituted. 
Timed Breeding Experiments 
To facilitate breeding experiments, proven breeder males were used 
(Harlan, Indianapolis, Indiana, USA).  Males were housed individually. Females 
were reproductively synchronized through the use of a synthetic luteinizing 
hormone releasing hormone (LHRH) (Sigma Aldrich, St. Louis, Missouri, USA).  
Females received 40 μg intraperitoneal injections of LHRH suspended in PBS 
supplemented with 1% bovine serum albumin (BSA) between 9 am and 11 am.  
The LHRH induced a luteinizing hormone (LH) surge, stimulating ovulation the 
following day.  Bovine serum albumin acted as a carrier protein for LHRH.  Rats 
were placed into a male’s cage five days later, on the evening of proestrus, two 
females per male.  The injection and breeding schedule is displayed in Table 2.3.    
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 The next day, during the morning of estrus, mating was validated through 
the use of two different observations:  (1) presence of a vaginal plug and/or (2) 
the presence of sperm in the vaginal cytology.  All females that were determined 
to be pregnant on this Day 1 (D1) of pregnancy were then placed into one of four 
different groups, based on whether their embryos were to be cultured, or allowed 
to gestate to a specific day of development.  Figure 2.1 illustrates these groups 
and the number of rats included in each.     
The night before embryo collections were to take place, the in vitro embryo 
culture system was prepared.  Three types of culture media were utilized: 
 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) –modified Rat 
Embryo Culture Medium 1 (mR1ECM) ([Miyoshi et al. 1995] and modified by the  
Transgenic Core, University of Missouri, Columbia, Missouri):  This medium was 
used in manipulating reproductive tissues outside of the CO2 incubator (e.g. 
embryo collection and embryo isolation).  The HEPES in the mR1ECM medium 
was necessary to maintain physiological pH outside of a CO2-rich environment.   
 
1) 1C to 2C mR1ECM ([Miyoshi et al. 1995] and modified by theTransgenic 
Core, University of Missouri, Columbia, Missouri):  This high salt medium 
promoted the proper development of rat zygotes into two-cell stage 
embryos.  This bicarbonate-based buffer required CO2 in order to upkeep 
physiological pH.  The addition of BSA functioned in supplementing the 
growing embryos and increasing the surface tension of the medium.   
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2) 2C to Blastocyst mR1ECM ([Miyoshi 1995] and modified by theTransgenic 
Core, University of Missouri, Columbia, Missouri):  This low salt medium 
supported development of rat two-cell stage embryos into blastocysts.  
This bicarbonate-based buffer required CO2 in order to maintain 
physiological pH. 
The Heracell 150i incubator atmosphere was set at 5% CO2, 95% air, 37°C, 
and 98% humidity (ThermoFisher Scientific, Palm Beach, Florida, USA).  See 
Table 2.4 for a list of all media components and concentrations, osmolality, pH, 
and temperatures. 
Initially, the HEPES-mR1ECM, placed into a tightly capped container, was 
transferred into a CO2 incubator (5% CO2, 95% air, 37°C, 98% Humidity).  This 
acted to prevent the disruption of the medium’s pH, while maintaining appropriate 
temperature prior to experiments.  The 1C to 2C mR1ECM medium was mixed to 
a final concentration of 0.1% BSA and subsequently sterile filtered through a 
Millex® 0.22 μm filter (Millipore, Billerica, Massachusetts, USA) attached to a 5 
mL pipette (BD Syringe, Franklin Lakes, New Jersey, USA).  There is twofold 
reasoning for adding the BSA:  (1) to supplement the growth of the embryos as a 
protein source and (2) to prevent the collapse of the mineral oil-covered 
microdrops and aid in embryo manipulation.   
Three microdrops of 1C to 2C mR1ECM were pipetted into a flat, non-
embryotoxic culture plate (Figure 2.2). The two smaller drops were considered 
washes for the embryos prior to being cultured, while the larger drop was the 
embryo ‘resting home’ throughout development inside the incubator.  After one 
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milliliter of sterile-filtered, non-embryotoxic light mineral oil (LifeGlobal, Guilford, 
Connecticut, USA) was pipetted over the microdrops, the culture plates were 
placed into the Heracell 150i to equilibrate overnight after being loosely covered 
with their corresponding lids.  All of these steps were performed on the evening 
prior to Developmental D1.   
The 2C to Blastocyst mR1ECM medium is prepared similarly to the 1C to 
2C mR1ECM medium (Figure 2.3).  This specific solution was prepared on the 
evening prior to in vitro Developmental Day 2.  This later embryonic stage 
medium does not require additional components.  This is due, in part, to the 
presence of polyvinyl alcohol (PVA) (Irvine Scientific, Santa Ana, California) in 
the medium itself, which plays a similar role to that of BSA in the context of 
medium viscosity and embryo manipulation.   
Embryo Collections (In Vitro Groups) 
After rats were verified to have successfully bred on the morning following 
co-caging with a male, they were euthanized using a CO2 overdose, followed by 
an aortic transection.  The abdominal cavity of each female was then transected, 
and appropriate tissues were collected, including the entire intact reproductive 
tract.  Removal and measurement of the endometriotic implants in the Endo 
groups took place at this time, to validate that they had appropriately developed 
to 5 mm x 5 mm in size.  The Endo and Sham groups contained a single uterine 
horn, oviduct, and ovary, due to the surgery that they had undergone four weeks 
prior.  The no-surgery controls had two horns, two oviducts, and two ovaries.  
The tracts were carefully stripped of the attached fat with a pair of small surgical 
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scissors and then placed into warmed HEPES-mR1ECM medium, set at 37°C, 
and taken to a sterile cell culture room. 
 Under sterile conditions, the reproductive tracts and the HEPES medium 
were poured out into a non-embryotoxic plastic culture plate sitting on a 37°C 
heated stage of a Leica s8 AP0 light stereoscope (Leica Microsystems, Buffalo 
Grove, Illinois, USA).  All remaining embryo manipulations were performed under 
this microscope.  Removing the remainder of the fat, the oviducts and uterine 
horns were separated.  A pair of small dissecting scissors and 26G needles (26G 
x 3/8, BD Syringe, Franklin Lakes, New Jersey, USA)  attached to 1 mL syringes 
(BD Syringe, Franklin Lakes, New Jersey, USA) were used during this protocol.  
In order to collect the zygotes, the protruding area at the oviductal ampulla 
was first identified.  The ampulla was then torn and punctured using the two 26G 
needles.  After this puncture, the cumulus oophorus complexes were flushed out 
of the oviduct.  These were immediately collected using an Origio Stripper 
Pipette® (MidAtlantic, Mt Laurel, New Jersey, USA) with an attached 300 μl 
pipette tip, and placed into a 1% Bovine Hyaluronidase solution, diluted in 
HEPES-mR1ECM medium.  By gently pipetting the zygotes up and down in the 
Stripper Pipette®, the cumulus cells were removed over a period of three to five 
minutes.  The zygotes were then immediately placed into the 300 μl drop of 1C to 
2C mR1ECM that had been prepared the night before and equilibrated in the 
CO2 incubator (Figure 2.4).  This first drop was one of two washes, necessary to 
dilute and remove any of the toxic hyaluronidase solution from the zygotes.  The 
zygotes were then transferred into the second wash of mR1ECM.  
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Zygotes were placed into the final 500 μl drop of mR1ECM medium 
(Figure 2.3).  After placing a lid on top of the culture plate, this culture system 
was transferred back into the CO2 incubator, set to an atmosphere of 5% CO2, 
95% air, 37°C, and 98% humidity.  At this point, the embryos were cultured to 
either developmental Day 2 or developmental Day 4.  For those that were 
cultured to D2, images were taken on a Nikon N8008 camera (100X, 200X, and 
400X, Nikon, Tallahassee, Florida, USA) under a light microscope equipped with 
Hoffman optics on the afternoon of Developmental D2.  After these images were 
taken, the embryos were fixed in 2% formaldehyde, and prepared to be 
processed.  For those that were chosen to grow to D4, the embryos were 
switched from the 1C to 2C mR1ECM medium, to the ‘2C to Blastocyst’ 
mR1ECM medium on the afternoon of D2.  They were then allowed to grow out 
to the afternoon of l D4 in the CO2 incubator without further disturbance.  At this 
point, the embryos were imaged using the Nikon light scope, and fixed, similarly 
to the D2 embryos.  A diagram of the embryo culture timeline can be found in 
Figure 2.3. 
Embryo Collections (In Vivo Groups) 
 The in vivo derived embryos were used as a means of determining a 
‘baseline’ for embryo quality in the context of our experiments.  The rats gestated 
to either Pregnancy Day 2, or Pregnancy Day 4, prior to being euthanized with a 
CO2 overdose, followed by an aortic transection.  Reproductive tracts were then 
removed, identically to the in vitro rat groups, placed into the HEPES-mR1ECM 
medium heated to 37°C, and transferred to the sterile cell culture room.   
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For the in vivo D2 group, the oviducts were carefully teased away from the 
ovary and uterine horns with a small pair of surgical scissors.  Each Fallopian 
Tube was subsequently flushed with HEPES-mR1ECM medium using a 26G 
needle attached to a 1 ml syringe, two to three times per oviduct.  Afterwards, the 
embryos were quickly located under the Leica s8 APO light stereoscope, and 
fixed in formaldehyde.  For the in vivo D4 group, the oviduct and uterine horn 
were allowed to remain attached to one another, while the ovary was removed 
with small surgical scissors.  Using a 30g needle (30G, BD Syringe, Franklin 
Lakes, New Jersey, USA) attached to a one mL syringe, the components of the 
uterine horn were flushed up through the attached oviduct with HEPES-mR1ECM 
medium at least twice.  Next, the oviductal contents were flushed down through 
the uterine horn with this same solution using a 26c needle attached to a one mL 
syringe.  This flushing was performed at least two individual times, as well.  This 
dual flushing protocol was utilized because the 8 cell to 16 cell embryos were 
observed to be located at both the distal end of the oviduct, and uterotubal 
junction, on embryonic D4.  These multicell embryos were then located in a 
culture plate under the Leica s8 APO light stereoscope, equipped with a 37°C 
heated stage, and immediately placed into formaldehyde for fixation.    
Embryo Fixation 
As referred to above, all embryos were fixed in a formaldehyde solution 
post-collection. Nine-well glass plates were placed onto a heated tray, and 
allowed to warm up to 37°C.  Following this preparation, per each group of 
embryos, 400 μl of warmed, pure PBS was placed into two individual wells 
located side-by-side.  Four hundred μl of PBS, maintaining a 1.0% concentration 
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of polyvinyl pyrrolidone (PVP) (Irvine Scientific, Santa Ana, California), was then 
added to the third, adjacent well.  The PVP was used to help prevent the 
embryos from attaching/sticking to the bottom of the glass well during fixation.  A 
single cohort of embryos was pipetted into the well containing the 1.0% PVP 
solution.  Next, 100 μl of 10% formaldehyde was slowly added around the edges 
of the ‘PVP well’ in order to create a 2% formaldehyde/0.8% PVP solution.  The 
embryos then incubated for 40 minutes at room temperature.  This was done per 
every in vivo and in vitro derived rat embryo cohort. 
After the incubation period, embryos were removed and briefly washed in 
the two adjacent PBS wells to remove any remaining formaldehyde.  The 
embryos were subsequently transferred to a well in another 9 well glass plate 
that was labeled with the rat number.   
The nine well plates containing fixed embryos were covered with a second 
nine-well glass plate, and tightly wrapped in Saran Wrap® (Johnson and Sons™, 
Racine, Wisconsin, USA) in order to prevent evaporation and potential loss of the 
embryos upon transportation.  Embryos were immunolabeled and imaged no 
later than five to seven days after fixation. 
Embryo Processing and Imaging 
 A protocol from the laboratory of Peter Sutovsky was used to immunolabel 
the embryos [Schatten 2004].  The secondary antibodies conjugated to 
fluorescein isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate 
(TRITC), along with the nuclear stain 4',6-diamidino-2-phenylindole (DAPI)  were 
utilized.  Per each embryo cohort, this protocol took place in a single 9-well glass 
plate, utilizing a Stripper® Pipette with attached 300 μl pipette tips.  Embryos 
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were placed into a 400 μl volume of 0.1%% Triton X-100 in 0.1 M phosphate 
buffered saline (PBS) for 40 minutes in order to permeabilize the zonae and 
oolemmas.  The permeabilized embryos were transferred to 400 μl of a 0.1% 
Triton X-100/5% normal goat serum (NGS) solution diluted in 0.1 M PBS for 30 
minutes as a means of suppressing non-specific antibody binding.  Finally, 
embryos were placed into 100 μl of a 1:400 diluted solution of primary antibodies 
targeting the two de-ubiquitinating enzymes (DUBs), Ubiquitin C-Terminal 
Hydrolase L1 (UCHL1) and Ubiquitin C-Terminal Hydrolase L3 (UCHL3) 
overnight.  Primary antibodies were diluted in 0.1% TritonX/1% NGS in 0.1 M 
PBS.   
After an overnight incubation at +4°C in the primary antibody solution, 
embryos were briefly placed through two 400 μl washes of 0.1% TritonX/1% NGS 
in 0.1 M PBS.  Embryos were then transferred into 400 μl of a 1:200 diluted 
secondary antibody solution for 40 minutes.  As with the previous solutions, 
these secondary antibodies were diluted using 0.1% Triton X-100/1%NGS in 0.1 
M PBS.  Due to the light sensitive nature of these fluorescent secondary 
antibodies, this solution was covered with tin foil throughout the incubation 
period.  The FITC-conjugated antibody tagged the UCHL1-primary antibody, the 
TRITC-conjugated antibody tagged the UCHL3-primary antibody, and the DAPI 
targeted nucleic acids.  Finally, the embryos were mounted onto a glass slide 
using a small drop of VectaShield® mounting medium (Vector Labs, Burlingame, 
California, USA), covered with a glass cover slip, and the cover slip sealed with 
Insta-Dri® translucent nail polish.  Once labeled with the fluorescent antibodies, 
64 
 
the embryos were minimally exposed to light.  All steps of the fixation protocol 
were performed under the Nikon SMZ645 microscope (Nikon, Tallahassee, 
Florida, USA).     
Images were taken on a Nikon Eclipse 800 epifluorescence microscope 
(Nikon, Tallahassee, Florida, USA) equipped with a Cool Snap camera 
(Photometrics, Tuscon, Arizona, USA).  These images, along with those taken 
under the dissecting microscope, were analyzed, evaluated, and compared 
between the three groups:  Sham, No-Surgery Control, and Endo.   A list of 
specific comparisons and criteria is referenced in Figure 2.4. 
General Categories of Analysis 
All in vivo and in vitro derived embryos were evaluated through the 
utilization of two primary categories:   (1) morphology and (2) UCHL1 and UCHL3 
localization.  The morphological comparisons were broken down into categories 
based on levels of blastomere quality, nuclear quality, and total cell number.   
Comparison of Embryo Fragmentation 
 Embryo fragmentation was evaluated by utilizing a scale that contained 
two categories of blastomere fragmentation:  0%-<50% fragmentation versus 
50%-100% fragmentation.  This category was evaluated based on what 
percentage of the entire embryo volume appeared to be fragmented.  See Figure 
2.5 for a breakdown of each fragmentation category.   Each embryo cohort per 
rat was evaluated by referencing images taken under a light microscope.  
Blastomere fragmentation levels were then compared among all of the groups on 
either Day 2 or Day 4 of development.   This was done by separating out 
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embryos that showed <50% fragmentation, from those that showed >50% 
fragmentation, and performing a logistic analysis to compare between all groups.   
Developmental Stage 
 Each embryo per each rat cohort was evaluated on the basis of 
appropriate embryonic stage on either developmental D2 or D4.  The average 
number of nuclei per embryo per rat was determined and compared between 
Control, Sham, and Endo groups on either Day 2 or Day 4 of development.  Light 
microscope images were used as a means of performing this data analysis.  Only 
embryos in which individual nuclei could be distinguished were included.  See 
Figures 2.6 and 2.7, respectively, for an example of proper D2 and D4 
developmental stages.  
Nuclear Quality 
 Each embryo nucleus per each embryo cohort was evaluated on the basis 
of nuclear quality.  Any embryo that exhibited nuclear fragmentation, nuclear 
pyknosis, and/or chromosomal misalignment was considered abnormal.   The 
average number of abnormal nuclei per embryo per rat was calculated, and 
compared between all groups on either D2 or D4 of development.  To accurately 
represent the data, only embryos with distinguishable blastomeres were included 
(e.g. those without severe fragmentation).  Images of DAPI-labeled embryos 
were referenced as a means of evaluating this specific category of morphological 
analysis.  See Figure 2.8 for an example of normal versus abnormal nuclear 
quality in a 2C stage embryo.     
Other Embryonic Abnormalities 
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Presence of vacuoles within the cytoplasm, uneven blastomere size, and 
granular cytoplasm are other proven signs of reduced embryo quality.  These 
characteristics were identified by reviewing light microscope images taken on a 
Nikon N8008 camera per each rat embryo.  No statistical analysis was performed 
using these specific categories of data, due to the fact that it was difficult to 
consistently define these characteristics between two different observers.  See 
Figure 2.9 for an example of each type of embryonic anomaly.   
UCHL1 Localization 
Each embryo cohort per rat was evaluated immunolocalization of UCHL1.  
Ubiquitin C-Terminal Hydrolase L1 was immunolabeled green by using a FITC-
conjugated fluorescent secondary antibody.  Localization was characterized by 
referencing images taken on a Nikon Eclipse 800 microscope.  The two 
categories used in this analysis included ‘Diffuse UCHL1’ and ‘Cortically-Located 
UCHL1’.  Localization was compared between the different groups on either 
developmental D2 or D4.   
UCHL3 Localization 
Each embryo cohort per rat was evaluated by determining the localization 
of UCHL3.  Ubiquitin C-Terminal Hydrolase L3 was immunolabeled red by using 
a TRITC-conjugated fluorescent secondary antibody.  The two categories used in 
this analysis included ‘Diffuse’ and ‘Nuclear’ localization of UCHL3.  Localization 
was compared between the different groups on either developmental D2 or D4.   
Statistical Analysis  
Logistic regression analysis using SAS GLIMMIX software was chosen to 
compare differences in levels of embryo fragmentation, and UCHL1 or UCHL3 
67 
 
localization between the different groups.  This form of analysis was utilized due 
to the variability in sample size per group, the multilevel data (Trial Number, In 
Vitro/In Vivo, and Experimental Group), and the binomial nature of the data.  The 
statistical model for this analysis is as follows:  log(P(Y = 1)/P(Y = 0)) = 
XB+ZU+e, where ‘B’ and ‘U’ are considered vectors of the specific parameters 
that were estimated from the data.  The ‘B’ denotes the fixed effects, ‘U’ the 
random effects, and ‘e’ the error term.  The ‘Z’ refers to a set of indicator 
variables denoting the ‘batch effect’, referring to the three separate experimental 
trials included in the analysis.  The ‘X’ is denoted as Control, Sham, or Endo, and 
‘Y’ the specific category of analysis.   The left side of the equation, expressed as 
log(P(Y=1)/P(Y=0)), is known as the log odds, and takes the binomial nature of 
the data into consideration.  Any p < 0.05 was considered statistically significant.   
Statistical comparisons between Control, Sham, and Endo groups are displayed 
as Odds Ratios for each of the aforementioned categories.   An Odds Ratio is the 
ratio of the probability of an event ‘occurring’, to the probability of that same 
event ‘not occurring’.   
A hierarchal regression model of analysis was also utilized to determine 
the differences in the mean total nuclei number per embryo per rat, along with 
the differences in the mean total abnormal nuclei number per embryo per rat, for 
similar reasons (difference being that this type of data is not binomial).  The 
statistical model of analysis is slightly different, being expressed as follows:  
Y=XB+ZU+e.  All basic terms in the equation are defined similarly as in the 
previous paragraph.   A p < 0.05 was considered statistically significant.   
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STAGE 
 
CELL TYPES IN VAGINAL CYTOLOGIES 
 
Proestrus 
 
Rounded epithelium 
 
Estrus 
 
Cornified epithelium 
 
Diestrus I 
 
Few cornified epithelial cells and white 
blood cells 
 
 
Diestrus II 
 
Predominantly white blood cells and a few 
rounded epithelial cells 
 
Table 2.1:  Stages of Estrous 
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In Vivo 
Day 2 (n=10)        Day 4 (n=9) 
Control (n=6) Sham (n=9)  Endo (n=7) 
In Vitro 
Day 2 (n=21)       Day 4 (n=32) 
Control (n=12) Sham (n=18) Endo (n=23) 
Figure 2.1: Experimental Groups.  A breakdown of the multiple groups that were 
utilized throughout the embryo culture experiments.  Each of the in vivo and in 
vitro groups were formaldehyde-fixed on either developmental D2, or 
developmental D4.  Each of these included three different subgroups of rats:  No-
Surgery Control, Sham, or Endo.  ‘n’ = total number of rats per each group. 
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GROUP TYPES 
 
DESCRIPTION 
 
Sham 
 
Unilateral ovariohysterectomy 
 
Endo 
 
Unilateral ovariohysterectomy+ 
Endometrial Implants 
 
No-Surgery Control 
 
 
No surgery performed 
Table 2.2:  Surgical Groups 
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D0 D1 D2 D3 D4 D5 
 Estrus Diestrus Diestrus Proestrus Estrus 
LHRH 
Injection 
   Breed Pregnant 
Table 2.3:  Rat Estrous Synchronization Schedule 
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mR1ECM 
+HEPES 
mR1ECM 
 (High NaCl) 
mR1ECM1 
 (Low NaCl) 
Sodium Bicarbonate 5 mM 25 mM 25 mM 
Sodium Pyruvate 0.5 mM 0.5 mM 0.5 mM 
MEM NEAA 100x 0.5x 0.5x 0.5x 
MEM EAA 50X 0.5x 0.5x 0.5x 
GlutaMAX 1* 0.1 mM 0.1 mM 0.1 mM 
CaCl2-2H2O 2 mM 2 mM X 
MgCl2-6H2O 0.5 mM 0.5 mM X 
NaCl 110 mM 110 mM 80 mM 
KCl 3.2 mM 3.2 mM 3.2 mM 
D-Glucose 7.5 mM 7.5 mM 7.5 mM 
Pennicillin G K Salt 100 μg/ml 100 μg/ml 100 μg/ml 
Streptomycin Sulfate 50 μg/ml 50 μg/ml 50 μg/ml 
Sodium Lactate 
(60% syrup) 13.53 mM 13.53 mM 13.53 mM 
HEPES 22 mM 0 0 
PVA 0 0 1 mg/mL 
BSA 0 0.1% 0 
OSMOLALITY: 
290-320 
mOsm 
280-300  
mOsm 
235-255  
mOsm 
pH: 7.4 7.4 7.4 
TEMPERATURE: 37°C 37°C 37°C 
Table 2.4:  Comparison of Rat Embryo Culture Media1 
1  
Critser [Unpublished] as modified from [Miyoshi et al. 1995] 
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Culture 
Media 
 
Category 
 
 
% Embryo 
Development 
 
Collection 
Stage 
 
Investigator/ 
Researcher 
 
mR1ECM 
single 
stage 
90% 
Blastocyst 
Day 5 
 
Miyoshi                         
[Miyoshi et al. 1995] 
mR1ECM 
sequential 
stage 
75% 
Blastocyst 
Day 5 
 
Critser                       
[Unpublished] 
mR1ECM 
sequential 
stage 
60%         
Morula 
Day 4 
 
Hennings1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
Dr. John Critser’s media protocol was utilized for Hennings’ experiments.  These are the 
media that are displayed and compared in Table 2.4.   
Table 2.5:  Comparison of Embryo Development in Chemically Defined Media  
74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Embryo Culture Diagram.  A diagram of the embryo culture 
setup used for the rat in vitro experiments.  Both the 1C to 2C mR1ECM 
and 2C to Blastocyst mR1ECM are set up in an identical manner. 
             
300 microliters mR1ECM                    
WASH 1 
500 microliters mR1ECM                                  
CULTURE MEDIUM 
300 microliters mR1ECM                    
WASH 2 
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Figure 2.3:  Timeline of Rat Embryo Culture.  A diagram of rat embryo 
collection, culture, and fixation in a sequential media system (mR1ECM).  
‘D1-D4’ = days of embryonic development. 
= Embryo Fixation 
 
   
= Change Media 
 
 
Collection Medium 1 
(High NaCl) + HEPES 
Culture Medium 1   
(High NaCl) + HCO
3
-
 
Culture Medium 2  
(Low NaCl) + HCO
3
-
 
 -   -  -    
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Figure 2.4: Experimental Design.   Experimental comparisons between 
Control, Sham, and Endo groups, in vivo vs. in vivo (red line) and in vitro vs. in 
vitro (black line). 
 
 
        Control 
D2 OR D4 
        Sham         Endo 
Vitro Vitro Vivo Vivo Vitro Vivo 
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0%to <50% 
             
50% to 100% 
             
Figure 2.5:  Comparison of Embryo Fragmentation.    Original 
magnification 200X.  Examples of varying degrees of blastomere 
fragmentation, including 0% to <50%; 50% to 100%.   
 
             
D2 
             
D4 
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Figure 2.6: Stages of D2 Embryo Development.  Original magnification 200X.  
Representative cohort of embryos on D2 from a no-surgery control rat, developed in 
vitro.  In rats, D2 embryos should be at the 2C stage or greater.   
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Figure 2.7: Stage of D4 Embryo Development.  Original magnification 
40X.  Examples of characteristically normal embryos on D4 of development.  
In rats, D4 embryos should be at the 8C stage or greater.   
 
 
 
 
                                                                                     
 
80 
 
                               
        
 
 
 
 
 
 
 
 
 
 
 
                DAPI                                                   DIC 
(A)                                                                      (B) 
Figure 2.8:  Nuclear quality.  Original magnification 600X.  Normal vs. abnormal 
nuclear morphology.  (A)  A 10 cell to 12 cell stage rat embryo.  Nuclei are blue 
(DAPI stain) Red arrows indicate abnormal nuclei  (B)  A DIC image(A).  The black 
circle indicates a cluster of blastomere fragments.   
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Figure 2.9: Other Embryonic Abnormalities.  Original magnification 200X. 
(A)  Zygotes with darkened, granular cytoplasm  (B) D2 embryo with uneven, 
different sized blastomeres (C) Fragmented embryos with abnormally-shaped 
blastomeres and vacuoles  (D)  Atretic D4 embryo.  Blue arrows indicate 
abnormal embryos. 
    
 
(A)                                                       (B) 
(C)                                                       (D) 
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RESULTS 
 
Day 2 of Embryonic Development 
 
In Vitro and In Vivo Comparison 
 There were no significant differences observed between the in vivo and in 
vitro derived embryos on D2, when comparing within each of the three 
experimental groups (Control, Sham, and Endo), in the categories of blastomere 
fragmentation, total nuclei number per embryo, abnormal nuclei number per 
embryo, or UCHL1/UCHL3 localization.  Thus, all Control, Sham, and Endo 
values in each of the in vitro and in vivo groups were pooled for subsequent 
analyses.  In vivo and in vitro group data is separated out and compared in 
Figures 2.10, 2.11, and 2.12, and Tables 2.6b, 2.7, and 2.8.   
Embryo Fragmentation 
 The number of embryos exhibiting greater than 50% blastomere 
fragmentation did not statistically differ between Control, Sham, and Endo 
(Figure 2.10 and Table 2.6b).  The majority of embryos per each group fell into 
the less than 50% fragmentation category.   Table 2.6a shows each experimental 
group to another by using Odds Ratios, or the relationship between the 
proportion of >50% fragmented embryos to <50% fragmented embryos between 
Control, Sham, and Endo.   
Appropriate Stage of Development 
 On D2 of development, rat embryos should be at the two-cell stage or 
greater.  The average nuclei count per embryo per rat did not statistically differ 
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when comparing between Control, Sham, and Endo (Figure 2.11 and Table 2.7).  
On average, the majority of embryos in each of the three groups contained a 
mean total of two nuclei.   
Abnormal Nuclei 
 The average number of abnormal nuclei per embryo per rat did not differ 
between Control, Sham, and Endo (Figure 2.12 and Table 2.8).  The majority of 
embryos in each group, on average, exhibited less than one abnormal nucleus 
per embryo per rat.  It is important to note that the in vitro Endo group exhibited a 
high level of variance.   
UCHL1 and UCHL3 Localization 
 The localization of UCHL1 and UCHL3 did not differ between Control, 
Sham, and Endo groups.  Ubiquitin C-Terminal Hydrolase L1 was predominantly 
localized around the periphery of individual cells in the two and four cell stage 
embryos in all groups.  Ubiquitin C-Terminal Hydrolase L3 showed predominant 
localization around intact, healthy nuclei, while remaining diffuse in blastomeres 
that had fragmented nuclei, in all three experimental groups.   
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Figure 2.10:  Percentage of D2 Embryos with >50% Fragmentation1,2   
1 
Values within each bar denote the total number of embryos that were analyzed 
per each group (corresponding to Table 2.6b) 
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2 
a:  Same letter above all bars indicates no significant differences between groups       
(p > 0.05) 
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IN VITRO  IN VIVO  
 
Control Sham Endo Control Sham Endo 
 
N=rats(embryos) 
 
 
9 (55) 
 
6 (47) 
 
11 (76) 
 
 
1 (11) 
 
6 (22) 
 
5(25) 
 
  p-value  Odds Ratios 
Control vs. Endo  0.4 0.6 
Control vs. Sham 0.2 0.9 
Endo vs. Sham  0.1 0.8 
 
1 
No statistical differences were observed (p > 0.05) 
 
Table 2.6a:  D2 Embryo Fragmentation Analysis1 
 
Table 2.6b:  D2 Embryo Fragmentation Group Numbers 
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Figure 2.11:  Average Number of Nuclei Per D2 Embryo1,2   
1 
Values within each bar denote the total number of embryos that were analyzed 
per each group (corresponding to Table 2.7) 
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a:  Same letter above bars indicates no significant differences between groups    
(p > 0.05) 
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IN VITRO  IN VIVO  
 
Control Sham Endo Control Sham Endo 
Mean # 
Nuclei/Embryo/ 
Rat (x¯ ±SEM) 
2.5± 
0.1a 
 
2.1± 
0.1a 
 
2.3± 
0.1a 
 
2.01± 
0.1a 
 
2.2 ± 
0.1a 
 
2.3± 
0.1a 
 
 
N=rats(embryos) 
 
4 (38) 
 
5 (54) 
 
12 (79) 
 
4 (28) 
 
4 (15) 
 
2 (12) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.7:  D2 Embryo Mean Total Nuclei Counts1 
1 
a:  Same letter across the same row indicates no significant differences between 
groups (p > 0.05) 
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Figure 2.12:  Average Number of Abnormal Nuclei Per D2 Embryo 1,2 
1 
Values within each bar denote the total number of embryos that were analyzed 
per each group (corresponding to Table 2.8). 
 2 a:  Same letter above bars indicates no significant differences between groups 
(p > 0.05) 
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IN VITRO GROUPS IN VIVO GROUPS 
 
Control Sham Endo Control Sham Endo 
Mean # Abnormal 
Nuclei/Embryo/Rat 
(x¯ ±SEM) 
0.4± 
0.1a 
 
0.6 ± 
0.02a 
 
0.5 ± 
0.1a 
0.2± 
0.03a  
0.2± 
0.01a 
0.1± 
0.1a 
 
N=rats(embryos) 
 
4 (38) 5 (54) 12 (79) 4 (28) 4 (15) 2 (12) 
 
                                                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.8:  D2 Embryo Mean Abnormal Nuclei Counts1 
1  
a:  Same letter across the same row indicates no significant differences between 
groups (p > 0.05). 
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Day 4 of Embryonic Development 
 
In Vitro and In Vivo Comparison 
 There were no significant differences observed between the in vivo and in 
vitro groups on D4, when comparing within each of the three experimental 
groups (Control, Sham, and Endo), in the categories of blastomere 
fragmentation, total nuclei number per embryo, abnormal nuclei number per 
embryo, and UCHL1/UCHL3 localization.  Thus, all Control, Sham, and Endo 
values in each of the in vitro and in vivo derived groups were pooled for 
subsequent analyses.  In vivo and in vitro derived group data is separated out 
and compared in Figures 2.13, 2.14, and 2.15, and Tables 2.9b, 2.10, and 2.11.  
Embryo Fragmentation 
 There was a difference in the number of embryos that develop greater 
than 50% fragmentation when comparing Control and Endo groups (p < 0.05).  
There was no statistical difference observed in this category of analysis when 
comparing Control and Sham, and, Sham and Endo, groups (Figure 2.13 and 
Table 2.8b).  Table 2.4a statistically compares each experimental group to 
another by using Odds Ratios, or the relationship between the proportion of 
>50% fragmented embryos to <50% fragmented embryos between Control, 
Sham, and Endo.  P-value of <0.05 denotes a significant difference. 
Stage of Development 
 Rat embryos should be at the 8C stage or greater on D4 of embryonic 
development.  Endo Day 4 embryos had fewer cells than Sham or No Surgery 
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Control groups (p < 0.05) (Figure 2.14 and Table 2.10).    There was no 
difference observed between the No Surgery Control and Sham rat groups.   
Abnormal Nuclei 
 The Endo embryos, on average, showed approximately two more 
abnormal nuclei per embryo per rat compared to the No-Surgery Controls, and 
Shams (Figure 2.15 and Table 2.11).  These differences were considered to be 
significant, exhibiting p < 0.05.  The average number of abnormal nuclei per 
embryo per rat was not different between Sham and Control groups.   
UCHL1 and UCHL3 Localization 
 There was no difference in the localization of UCHL1 (diffuse vs. cortical) 
and UCHL3 (diffuse vs. nuclear) when comparing Control, Sham, and Endo. 
While there was a tendency for Endo embryos to show diffuse UCHL1 
localization when compared to Control and Sham embryos, this did not reach 
statistical significance.  Also:  fragmented embryos had a greater tendency to 
exhibit diffuse UCHL1, and diffuse UCHL3, when compared to intact embryos, in 
all groups.  Typically, UCHL3 would be expected to co-localize with the nuclei 
and mitotic spindles, and UCHL1 with the cortex.  See Figure 2.16 for a 
representative panel per each of the D4 Control, Sham, and Endo embryos.  
Figures 2.17a and 2.17b display the percentages of embryos with diffuse UCHL1 
and UCHL3, respectively.   
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Figure 2.13:  Percentage of D4 Embryos with >50% Fragmentation1,2 
1 
Values within each bar denote the total number of embryos that were analyzed 
per each group (corresponding to Table 2.9c) 
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2 
a,b:  Different letters above bars indicate significant  differences (p < 0.05) 
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        a 
        a 
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 p-value  Odds Ratio 
Control vs. Endo* 0.04 0.2 
Control vs. Sham 0.4 0.5 
Endo vs. Sham 0.2 3.0 
 p-value 
Control (vitro) vs. Control (vivo) 0.9 
Sham (vitro) vs. Sham (vivo) 0.3 
Endo (vitro) vs. Endo (vivo) 0.4 
 
IN VITRO  IN VIVO  
 
Control Sham Endo Control Sham Endo 
 
N=rats(embryos) 
 
10 (67) 
 
17 (104) 
 
14 (124) 
 
2 (11)  
 
 
4 (38) 
 
4 (37) 
 
Table 2.9a: D4 Embryo Fragmentation Analysis 
 
Table 2.9c:  D4 Embryo Fragmentation Group Numbers 
* 
Indicates a significant difference (p < 0.05) 
 
Table 2.9b: D4 Embryo Fragmentation Analysis (vivo vs. vitro)1 
 
1 
No significant differences were observed (p > 0.05) 
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Figure 2.14:  Average Number of Nuclei Per D4 Embryo1,2 
2 
a,b:  Different letters above bars indicate significant  differences (p < 0.05) 
 
1 
Values within each bar denote the total number of embryos that were analyzed 
per each group (corresponding to Table 2.10) 
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IN VITRO  IN VIVO  
 
Control Sham Endo Control Sham Endo 
Mean # of 
Nuclei/Embryo/Rat 
(x¯ ±SEM) 
 
10.9 ± 
1.1a 
 
9.1 ± 
1.3a 
 
6.4 ±  
1.8b 
 
9.3 ± 
0.5a 
 
8.0 ± 
0.01a 
 
7.4 ± 
0.1b 
 
N=rats(embryos) 
 
8 (55) 
 
13 (89) 
 
11 (100) 
 
2 (11) 
 
4 (27) 
 
3 (29) 
 
Table 2.10:  D4  Embryo Mean Total Nuclei Counts1 
1 
a,b:  Different letters across the same row indicate significant  differences (p < 0.05) 
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1 
Values within each bar correspond to the total number of embryos that were 
analyzed per each group (corresponding to Table 2.11) 
 
Figure 2.15:  Average Number of Abnormal Nuclei Per D4 Embryo1,2 
     55 
2 
a,b:  Different letters above bars indicate significant differences (p < 0.05) 
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IN VITRO  IN VIVO  
 
Control Sham Endo Control Sham Endo 
Mean # of 
Abnormal 
Nuclei/Embryo/Rat 
(x¯ ±SEM) 
2.4 ± 
0.2a 
 
2.1 ± 
0.5a 
 
3.9 ± 
1.1b 
 
1.0 ± 
0.1a 
 
1.9 ± 
0.3a 
 
1.7 ± 
0.2 b 
 
 
N=rats(embryos) 
 
8 (55) 
 
13 (89) 
 
11 (102) 
 
2 (11) 
 
4 (27) 
 
3 (29) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 a,b:  Different letters across the same row indicate significant differences                                              
(p < 0.05) 
 
Table 2.11:  D4 Mean Abnormal Nuclei Counts1 
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Figure 2.16: D4 Embryo UCHL3 and UCHL1 Immunolocalization.  (A,B,C)  DAPI-
labeled images of Control, Sham, and Endo embryos. Nuclei counts were performed 
on these images.  Normal (green arrows) and abnormal nuclei (red arrow) are 
denoted appropriately. (D,E,F) UCHL1 immunolabeling of Control, Sham, and Endo 
embryos.  Cortical UCHL1 is denoted with a blue arrow, and diffuse UCHL1 with a red 
arrow.  (G,H,I)  UCHL3 staining of Control, Sham, and Endo embryos.  Nuclear 
UCHL3 is denoted with a blue arrow, and diffuse UCHL3 with a red arrow.  (J,K,L)  
Merged images of Control, Sham, and Endo embryos.   
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Figure 2.17a:  Percentage of Embryos with Diffuse UCHL1
1
 
2 
a:  similar letter above all bars indicates non-significance (p > 0.05)  
Figure 2.17b:  Percentage of Embryos with Diffuse UCHL3
1
 
2 
a:  similar letter above all bars indicates non-significance (p > 0.05)  
1 
Values within each bar correspond to the total number of embryos that were 
analyzed per each group (corresponding to Table 2.11) 
 
1 
Values within each bar correspond to the total number of embryos that were 
analyzed per each group (corresponding to Table 2.11) 
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UCHL1 UCHL3 
p-value 
Odds 
Ratio p-value 
Odds 
Ratio 
Control vs. Sham 0.4 0.9 0.2 1.1 
Control vs. Endo 0.1 0.4 0.2 0.7 
Sham vs. Endo 0.1 0.6 0.3 0.9 
Table 2.11:  D4 Embryo UCHL1 and UCHL3 Odds Ratio Analysis 
and UCHL3 Odds Ratio Analysis 
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DISCUSSION  
 
 
On D2 and on D4, no differences were found between in vitro and in vivo 
derived embryo development within Control, Sham or Endo rats for any of the 
experimental outcomes. Hence, in vivo and in vitro derived data were pooled and 
analysis was conducted between surgical groups. 
On D2, the majority of Control and Sham embryos exhibited a fairly high 
quality phenotype and had similar patterns of UCHL1 and UCHL3 protein 
localization.  Endo embryos had a similar total cell count and UCHL1/UCHL3 
immunolocalization pattern when compared to Sham and Control groups.  While 
no difference was observed in the number of abnormal nuclei between all 
groups, the in vitro Endo group displayed a high level of variance.  This is 
potentially indicative of either a treatment effect, or an adverse effect of the 
culture system.  The data shows that the effects of endometriosis on 
developmental D2 did not readily impact embryo development, did not become 
apparent at this stage or could not be discerned by morphology or UCHL1/L3 
localization.  
On D4, differences in embryonic development between Control, Sham and 
Endo embryos became apparent.  Control and Sham D4 embryos did not differ in 
developmental morphology, nuclear numbers, fragmentation or the number of 
abnormal nuclei per embryo.  Endo D4 embryos, on the other hand, were of a 
poorer quality, displaying significantly fewer total nuclei, greater fragmentation 
and more abnormal nuclei per embryo.  Compared to the D2 data, the in vitro D4 
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embryos exhibited a high level of variance in the total number of abnormal nuclei 
when compared to all other group types.  The data shows that in vitro culture 
may exacerbate the adverse effects of endometriosis on embryo development.  
Another potential conclusion is that the effects of endometriosis begin to 
predominantly manifest at some time point between D2 and D4 of 
preimplantation development.  This range of time corresponds to the maternal to 
zygotic transition (MZT) in rats and the point at which the multicellular embryos 
begin to undergo compaction and cellular differentiation.  A final conclusion from 
the D4 embryo data involves the null hypothesis.  Endo embryos are unable to 
be rescued from the effects of endometriosis when removed from the mother at 
the zygote stage and transferred into an established culture system.   
Temporal and spatial gene expression and epigenetic control is important 
for many embryonic physiological processes, ranging from the degradation of 
maternal mRNA throughout the MZT to the timed expression of proteins involved 
in cellular cleavage and DNA replication [Kanka 2003; Harvey et al. 2007].  If 
these processes are disrupted, embryos may not properly develop.  In the 
context of our in vitro endometriosis rats, it seems that early exposure to elevated 
levels of ROS and negative proinflammatory factors such as tumor necrosis 
factor alpha (TNFα) prior to cleavage may disrupt later stage processes.  It has 
been reported that external stressors (e.g ROS and TNFα) can disrupt the 
transcriptome of the oocyte and early stage embryos, in which one effect may be 
a reduction in functional microRNA (miRNA) [Sirard 2012].  This, in turn, would 
lead to the delayed removal of maternal mRNA, in which an accumulation can be 
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detrimental to the later stage embryo.  This may be the cause of the increased 
abnormalities observed in our D4 Endo embryos.  Also, previous studies 
documented that Endo embryos tended to arrest at the 8C stage of development 
in vivo [Stilley et al. 2009], which is well correlated with observations made in the 
present study.     
In conclusion, early exposure to Endo lesion secretions may lead to  
delayed or disrupted embryonic development, such as the MZT, which could very 
well be causative of delayed embryo development and an increased number of 
abnormal nuclei per embryo.  This in turn may explain why Endo embryos cannot 
be salvaged by growing them in an established culture system, and why culture 
seems to exacerbate the abnormal effects of surgically induced endometriosis.     
The UCHL1 and UCHL3 localization was determined per each of the D2 
and D4 embryos.  It has been previously observed in our lab that multiple 
apoptotic genes were dysregulated in the 8C embryos of Endo rats, including 
Diablo, Casp3, Parp1, and Dnaja3 [Birt et al. 2013].  An accumulation of 
cytoplasmic proteasomes was also observed within the early-stage 
preimplantation embryos from this same Endo rat model, indicative of elevated 
cellular stress [Stilley et al. 2010].  As a way to further characterize the effects 
that endometriosis has on programmed cell death, the de-ubiquitinating enzymes 
UCHL1 and UCHL3 were analyzed [Driscoll 1994; Larsen et al. 1998].  While 
there was no observed statistical difference between any of the groups, there 
was a tendency for the D4 embryos in Control and Sham rats to display cortically 
located (normal) UCHL1 when compared to Endo rats, in which UCHL1 
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localization was predominantly diffuse.  It is important to mention that a large 
proportion of the diffuse UCHL1 embryos were severely fragmented.   
It is impossible to determine if UCHL1 destabilization from the cortex is a 
cause or an effect of the embryonic detriment.  While little is known about the 
involvement of UCHL1 in preimplantation development, it was reported that 
mutant gad mice lacking UCHL1 have a tendency to arrest at the morula stage, 
exhibiting an inability to compact [Mtango et al. 2012].  It is possible that UCHL1 
is involved in the tightly regulated interaction between the outer cells of the 
compacting morula.   
Ubiquitin c-terminal hydrolase L1 is also important in binding to and 
increasing the half-life of ubiquitin [Yi et al. 2007; Koyanagi et al. 2012].  This 
DUB may be necessary to maintain stable pools of ubiquitin at the cortex, 
significant in regulating the internalization of certain transmembrane proteins, 
and degradation of misfolded peptides present in the endoplasmic reticulum 
[Bonifacino and Weissman 1998].  This may be an explanation behind the 
elevated number of abnormal embryos observed in the Endo group and a 
proposal that UCHL1 deregulation may contribute to embryonic abnormalities.   
In conclusion, our research data indicates that the in vitro culture of 
preimplantation embryos from women with endometriosis in IVF clinics may not 
be a solution for improved preimplantation development.  This is predominantly 
due to the early-stage effects of endometriotic lesion secretions before embryos 
are taken out of the endometriotic environment, potentially exacerbated by 
culture medium.   These adverse effects become obvious on D4 of development, 
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as observed in our experiments.  In order to further characterize our data, gene 
analysis should be performed on Control, Sham, and Endo embryos to determine 
the expression levels of UCHL1, UCHL3, and MZT-associated transcripts on D2 
and D4 of development.   
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CHAPTER 3 
 
 
 
 
COMPARING THE QUALITY OF BLASTOCYST 
DEVELOPMENT IN A SEQUENTIAL CULTURE SYSTEM 
VERSUS A SINGLE CULTURE SYSTEM 
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INTRODUCTION 
 
 
  Culture media for embryonic growth and development include amino 
acids, carbohydrates, a variety of salts and other components.  Many of these 
components play roles in the regulation of embryonic processes, ranging from 
metabolism to the maintenance of intracellular osmolality and redox potential 
[Naaktgeboren 1987; Oh et al. 1998; Van Winkle 2001; Han and Niwa 2003].  
They are also known to interact with each other, leading to an elevated 
complexity in the development of different types of culture media.   
For example, the effect of glucose toxicity on early cleaving mammalian 
embryos can be alleviated by including non-essential amino acids and glutamine 
in the media.  Lactate, at a low concentration, is also known to be beneficial to 
early embryo development in conjunction with amino acids and pyruvate, but 
toxic when present by itself and at elevated concentrations [Bavister 1995, Lane 
and Gardner 1998].  Early cleaving embryos, of all studied mammalian species, 
have a limited control over their internal environment, compared to later-stage, 
compacted embryos [Eckert et al. 1997; Rizos et al. 2003; Yamada et al. 2012].  
This concept has been taken into consideration during optimization of culture 
media systems.   
 According to the Center for Disease Control, an estimated 85,000 women 
undergo in vitro fertilization (IVF) procedures in the United States each year; on 
average spending $12,400 per cycle.  Further, the number of assisted 
reproductive technology (ART) cycles per year is steadily on the rise, the current 
average reported as 135,000 cycles per year.   
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Numerous studies conducted over decades have utilized a variety of 
animal models to create an optimal culture system for human embryos [Whitten 
1957; Miyoshi et al. 1995; Rizos et al. 2003].  Human embryos cannot be used 
for experimentation due to ethical restrictions.  There are numerous brands of 
culture media on the market, both of the single and sequential types.  An 
example of a single medium is Global® (LifeGlobal, Guilford, Connecticut, USA), 
while an example of a sequential media is EmbryoAssist™/BlastAssist™ (Origio, 
Mt. Laurel, New Jersey, USA).  The issue of using single culture versus two-step 
culture remains controversial. The argument is that while single culture may be 
more beneficial due to a consistent culture environment and reduced embryonic 
manipulation, a sequential system more successfully mimics the changing 
environment of the entire human reproductive tract [Artini et al. 2004; Lane and 
Gardner 2007]. 
 Human ART began in the late 1970s with single medium and then moved 
to sequential media as our knowledge of embryo requirements advanced [Lane 
and Gardner 2007].  Early IVF protocols would grow embryos for two days in 
culture and transfer them back to the recipient at the 2 cell (2C) to 4 cell (4C) 
stage of development.  Approximately 20 years later, embryo culture systems 
had improved to permit culture to the blastocyst stage (developmental D5) [Lane 
and Gardner 2007].  Zygotes that are capable of developing to the blastocyst 
stage on developmental D5 are regarded as being of a higher quality in 
comparison to slower developing embryos.  Predictably, this protocol is capable 
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of selecting the best quality embryo(s) for transfer.  Further, fewer blastocysts 
can be transferred, reducing the risk of multiple pregnancies.   
In 2000, Biggers et al. found no differences in the hatching rates, or 
number of trophectoderm (TE) cells or inner cell mass (ICM) cells of murine 
blastocysts that were grown in a one-step culture KSOMAA (Sigma, St. Louis, 
Missouri, USA) versus a sequential system G1.2/G2.2  (Scandinavian IVF 
Science, Gothenburg, Sweden) [Biggers et al. 2000].  Conversely, a 2004 
retrospective meta-analysis concluded that sequential media lead to a greater 
number of developed human blastocyst stage embryos and a higher number of 
live births compared to single medium [Blake et al. 2004]. During this same time, 
other studies observed that while a specific single-stage culture lead to poorer 
quality human blastocysts compared to sequential, culture birth rates did not 
differ [Ben-Yosef et al. 2004].  This indicated a need for more sophisticated 
methods of embryo selection for transfer beyond embryo morphology to help in 
predicting pregnancy and live birth outcomes.   
Then, coming full circle, in 2009 and 2010, Paternot et al. and Reed et al. 
reported that a single media system led to the development of a greater number 
of human blastocysts when compared to a sequential system [Reed et al. 2009; 
Paternot et al. 2010].  The different outcomes observed among the 
aforementioned research studies may be due to the variability in media 
compositions, and specific embryo growth conditions used per each research 
laboratory.    
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The purpose of the present study was to determine the developmental 
potential, quality and possible mechanisms by which murine embryos 
differentially develop in sequential versus single media systems over a period of 
five days.  Nuclei numbers and nuclear quality were two primary categories 
evaluated and compared between embryos grown in either media type.       
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MATERIALS AND METHODS 
Murine Embryo Collection and Experimental Plan 
 All murine embryos that were used in these experiments were obtained 
from EmbryoTechTM, a company chosen due to its reputation for a high level 
product quality control. At EmbryoTech™, superovulated female B6C3F-1 and 
male B6D2F-1 mice were bred, and their zygotes subsequently collected.  These 
zygotes were pooled and randomly distributed into ThawAlert™ (EmbryoTech™, 
Haverhill, Massachusetts, USA) straws, 20 to 23 embryos per straw.  They were 
then cryopreserved and shipped to consumers. 
 All in vitro culture experiments were performed at the Missouri Center for 
Reproductive Medicine and Fertility in vitro fertilization (IVF) laboratories at the 
Women’s and Children’s Hospital (WCH) of Columbia, MO.  Embryos were fixed 
in 2% formaldehyde on developmental day 5, followed by processing and 
imaging.  All experiments were performed in accordance with the Animal Care 
and Use Committee regulations.   
 The purpose of this section of my Thesis was to determine the 
developmental potential of murine embryos in each of two different media types.  
One of these includes a single culture medium known as Global® medium 
(LifeGlobal, Guilford, Connecticut, USA), and the other is a sequential media 
system known as the P1® (Preimplantation Stage 1®)_Multiblast®  media (Irvine 
Scientific, Santa Ana, California).  Global® medium is the current media type 
being used at the Women’s and Children’s Hospital of Columbia, MO.  The 
P1®_Multiblast® system is commonly used in human IVF laboratories throughout 
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the United States, but has been replaced at Columbia’s WCH due to the 
observation that Global® tends to perform better than the former.  This chapter 
tackles the comparison between these two media, looking at quality and quantity 
of mouse blastocysts developed in these established in vitro environments.  
Murine Embryo Culture 
 On the morning of D1, two straws of murine embryos were thawed in 
accordance with EmbryoTech™’s protocol (EmbryoTech™, Haverhill, 
Massachusetts, USA).  Briefly: each ThawAlert™ straw was removed from the 
storage tank, placed at room temperature for two minutes, and then set into a 
37°C water bath for one minute.  Afterwards, both straws were cut open, and the 
embryos expelled into a drop of HEPES-buffered, modified Human Tubal Fluid 
(mHTF) (Irvine Scientific, Santa Ana, California, USA) using the provided stylet.  
Subsequently, the embryos were briefly washed in two more drops of the same 
medium and allowed to rehydrate in the second drop for a total of 10 seconds.  
Afterwards, the embryos were split between one of the two different culture 
media that had been equilibrated overnight in a Heracell 150i CO2 incubator 
(ThermoFisher Scientific, Palm Beach, Florida, USA), using an Origio Stripper® 
Pipette (MidAtlantic, Mt Laurel, New Jersey, USA) and 300 μl pipette tips. One 
milliliter volumes of media were set into double-well, non-embryotoxic culture 
plates.  The plates were then placed into the Heracell 150i incubator, set to an 
atmosphere of 6% CO2, 94% air, 37°C, and >98% humidity.  Observations on cell 
number and embryo quality were made on the mornings of developmental D2, 
D3, D4, and on the afternoon of D5 using an Olympus IX-71 Inverted Microscope 
(Olympus America, Center Valley, Pennsylvania, USA).  Light microscope 
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images were taken on D1, and D5, of development using an Olympus DP70 
digital camera (Olympus America, Center Valley, Pennsylvania, USA). 
 In both culture medium systems, the volume was changed on the 
afternoon of developmental D3.  See Table 3.1 for a comparison of each 
medium’s components, pH, osmolality, and temperatures.  In the context of the 
Global® group, embryos were transferred into fresh Global® medium using a 
Stripper® Pipette on D3.  In reference to the P1®_Multiblast® system, embryos 
were removed from the P1® medium supplemented with protein (D1 to D2), and 
switched to the Multiblast® medium (D3 to D5), using a Stripper® Pipette, on the 
afternoon of developmental D3.  All media were equilibrated the night before in a 
CO2 incubator set to an atmosphere of 6% CO2, 94% air, 37°C, and >98% 
humidity, covered in 1 mL of light mineral oil, before coming in contact with the 
embryos.  See Figure 3.3 for a basic timeline of the murine embryo culture 
experiments. 
Many IVF clinics routinely use mouse embryo culture as a means of 
human media quality control.  This protocol is known as a mouse embryo assay 
(EmbryoTech™, Haverhill, Massachusetts, USA).  The developmental potential 
of the P1®_Multiblast® culture system was compared to that of the Global® 
system during four of these scheduled MEAs.   
Embryo Fixation 
As referred to above, all in vivo and in vitro derived embryos were fixed in 
a formaldehyde solution post-collection. Nine-well glass plates were placed onto 
a heated tray, and allowed to warm up to 37°C.  Following this preparation, per 
each group of embryos, 400 μl of warmed, pure PBS was placed into two 
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individual wells located side-by-side.  Four hundred μl of PBS, maintaining a 
1.0% concentration of polyvinyl pyrrolidone (PVP) (Irvine Scientific, Santa Ana, 
California), was then added to the third, adjacent well.  The PVP was used to 
help prevent the embryos from attaching/sticking to the bottom of the glass well 
during fixation.  A single cohort of embryos was pipetted into the well containing 
the 1.0% PVP solution.  Next, 100 μl of 10% formaldehyde was slowly added 
around the edges of the ‘PVP well’ in order to create a 2% formaldehyde/0.8% 
PVP solution.  The embryos then incubated for 40 minutes at room temperature.  
This was done per every in vivo and in vitro rat embryo cohort. 
After this incubation period, the embryos were removed and briefly 
washed in the two adjacent PBS wells to remove any remaining formaldehyde.  
The embryos were subsequently transferred to a well in another 9 well glass 
plate that was labeled with the rat number.  This was considered the ‘final resting 
well’ for the embryos prior to processing. 
 The nine well plates containing the fixed embryos were then covered with 
a second nine-well glass plate, and tightly wrapped in Saran Wrap® (Johnson 
and Sons™, Racine, Wisconsin, USA) in order to prevent evaporation and 
potential loss of the embryos upon transportation.  Embryos were immunolabeled 
and imaged no later than five to seven days after fixation. 
Embryo Processing and Imaging 
 A protocol from the laboratory of Peter Sutovsky was used to fluorescently 
immunolabel the embryos [Schatten 2004].  The secondary antibodies 
conjugated to Fluorescein isothiocyanate (FITC) and tetramethyl rhodamine 
isothiocyanate (TRITC), along with the nuclear stain 4',6-diamidino-2-
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phenylindole (DAPI)  were utilized.  Per each embryo cohort, this protocol took 
place in a single nine well glass plate, utilizing a Stripper® Pipette with attached 
300 μl pipette tips.  Embryos were placed into a 400 μl volume of 0.1%% Triton 
X-100 in 0.1 M phosphate buffered saline (PBS) for 40 minutes in order to 
permeabilize the zonae and oolemmas.  These permeabilized embryos were 
transferred to 400 μl of a 0.1% Triton X-100/5% Normal Goat Serum (NGS) 
solution diluted in 0.1 M PBS for 30 minutes as a means of suppressing non-
specific antibody binding.  Finally, embryos were placed into 100 μl of a 1:400 
diluted solution of primary antibodies targeting the two de-ubiquitinating enzymes 
(DUBs), Ubiquitin C-Terminal Hydrolase L1 (UCHL1) and Ubiquitin C-Terminal 
Hydrolase L3 (UCHL3) overnight.  Primary antibodies were diluted in 0.1% 
TritonX/1% NGS in 0.1 M PBS.   
After an overnight incubation at +4°C in the primary antibody solution, 
embryos were briefly placed into two 400 μl washes of 0.1% TritonX/1% NGS in 
0.1 M PBS.  Embryos were then transferred into 400 μl of a 1:200 diluted 
secondary antibody solution for 40 minutes.  As with the previous solutions, 
these secondary antibodies were diluted using 0.1% Triton X-100/1%NGS in 0.1 
M PBS.  Due to the light sensitive nature of these fluorescent secondary 
antibodies, this solution was covered with tin foil throughout the incubation 
period.  The FITC-conjugated antibody tagged the UCHL1-primary antibody, the 
TRITC-conjugated antibody tagged the UCHL3-primary antibody, and the DAPI 
stain targeted nucleic acids.  Finally, the embryos were mounted onto a glass 
slide using a small drop of VectaShield® mounting medium (Vector Labs, 
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Burlingame, California, USA), covered with a glass cover slip, and the cover slip 
sealed with Insta-Dri® translucent nail polish.  Once labeled with the fluorescent 
antibodies, the embryos were minimally exposed to light.  All steps of the fixation 
protocol were performed under the Nikon SMZ645 microscope (Nikon, 
Tallahassee, Florida, USA).     
Epifluorescence images were taken on a Nikon Eclipse 800 
epifluorescence microscope (Nikon, Tallahassee, Florida, USA) equipped with a 
Cool Snap camera (Photometrics, Tuscon, Arizona, USA).  These images were 
analyzed, evaluated, and compared between the two groups:  P1®_Multiblast® 
and Global®. 
General Categories of Analysis 
 On D5 of embryogenesis, the embryos are expected to reach the 
blastocyst stage of development.  Blastocysts were imaged in each group, and 
simultaneously analyzed.  The following five categories of data were collected, 
analyzed, and compared between the Global® and P1®_Multiblast® grown 
embryos:  total cell number, presence of an inner cell mass (ICM), ICM cell 
count, trophoblast cell count and nuclear quality.  Immunofluorescent localization 
of UCHL1 and UCHL3 was used as a reference point for nuclear counts and 
embryo morphology.  Numbers of each embryo stage were also analyzed and 
compared on both D3 and D5 of development.   
Total Nuclei Number 
Total embryo nuclei numbers per blastocyst were determined by counting 
nuclei under a Nikon Eclipse 800 fluorescent microscope (600X), using a DAPI 
filter, per blastocyst.    The nuclei of each blastocyst were counted three 
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individual times, and averaged, by analyzing multiple planes of focus.  Any of the 
three nuclei counts that was considered to be an outlier (cell count mean ± 3 x 
standard deviation) was removed from the data set, and all counts were re-done.   
Presence of an Inner Cell Mass 
Using the UCHL1 and UCHL3 immunolocalization as a reference point, a 
presumptive ICM was distinguished under the Nikon Eclipse 800 microscope 
(400X, 600X) by analyzing multiple planes of focus per blastocyst.  The UCHL1 
had a tendency to weakly immunolocalize, and UCHL3 strongly, at the ICM.  
Intense DAPI labeling aided in the identification of the ICM.   
Inner Cell Mass Cell Count 
Once the presumptive ICM was identified, a presumptive ICM cell number 
was determined.  The predicted ICM cells were counted three individual times at 
600X (using the DAPI filter) under the Nikon Eclipse 800 microscope, with a five 
minute time gap between each count, compared, and then averaged.  Any of the 
three cell counts that was considered an outlier (cell count mean ± 3 x standard 
deviation) was removed, and all counts re-done in that specific blastocyst.  If an 
ICM could not be definitively located in a specific blastocyst, there was no ICM 
cell count performed. 
In embryos in which a presumptive ICM was clearly identified under the 
Nikon fluorescent microscope, presumptive ICM nuclear counts were re-done on 
DAPI-labeled images of blastocysts opened up in ImageJ [Abramoff et al, 2004]. 
twice, averaged, and then compared to the averaged microscope counts by 
using a One-Way ANOVA analysis.  One other researcher also counted and 
recorded presumptive inner cell mass numbers, twice, in an identical manner to 
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validate this counting protocol by using images opened up in ImageJ.  After the 
ImageJ count method was validated by statistically comparing the counts 
determined by both researchers, using a One-Way ANOVA, presumptive ICM 
counts were compared between the P1®_Multiblast® and Global® embryo 
groups.   
Trophoblast Cell Count 
The following calculation was performed to determine the total number of 
presumptive trophoblast cells per embryo: 
               Total Cell Count – Presumptive ICM Cell Count 
These values were then compared between the P1®_Multiblast® and Global® 
groups. 
D3 and D5 of Embryo Development 
The D3 embryos should ideally be at the 8C+ stage, while D5 embryos, 
should be at the blastocyst stage.  The total number of appropriately-staged 
embryos was compared on either developmental D3 or D5, between each of the 
two groups.  These numbers were obtained by examining images recorded on 
the Olympus IX-71 Inverted Microscope (400X).  These values were then 
compared between P1®_Multiblast® and Global® embryos on D3, and D5.     
Abnormal Nuclei 
Each blastocyst in each mouse cohort was evaluated on the basis of 
nuclear quality.  Any embryo that exhibited nuclear fragmentation, nuclear 
pyknosis, and/or chromosomal misalignment was considered abnormal.   
Abnormal nuclei were identified and counted under a Nikon Eclipse 800 
microscope equipped with a Cool Snap camera (200X, 400X, and 600X), using 
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UCHL1 and UCHL3-immunolabels as a reference point for individual cells.  
Multiple planes of focus were used in order to allow all nuclei to be taken into 
consideration.  These counts were performed as described above.  Averaged 
values were then statistically compared between the P1®_Multiblast® and 
Global® embryos.  See Figure 3.1 for an example of normal versus abnormal 
nuclear quality in a blastocyst.     
Hatching vs. Unhatched Blastocysts 
 The number of hatching/hatched blastocysts and non-hatching blastocysts 
was determined and compared between the P1®_Multiblast® and Global® 
groups.  All completely hatched and partially hatched blastocysts were combined 
into one group.  These characteristic were determined by referencing both 
fluorescent images taken on the Nikon Eclipse 800 microscope, and light 
microscope images taken on the Olympus IX-71 Inverted Microscope (400X) at 
WCH .  These numbers were then statistically compared between 
P1®_Multiblast® and Global® embryos.  See Figure 3.2 for an example of a 
hatching blastocyst vs. an unhatched blastocyst.   
Statistical Analysis 
A general linear mixed model (GLMM) was used to analyze differences in 
total nuclear number, presumptive ICM nuclear number, and presumptive TE 
nuclear number between the blastocysts grown in P1®_Multiblast® and Global® 
media.  Considering that four replicates of embryo growth and fixation were 
performed, a random effect was taken into consideration.  This allowed for data, 
collected at multiple different times, to be combined and analyzed together.  
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Once the least square means were calculated, an approximate t-test was used to 
compare differences in total nuclei number through the software known as SAS 
9.22 PROC MIXED.  The statistical model for this analysis is expressed as 
follows:  Y = XB+ZU+e, where ‘B’ and ‘U’ are considered vectors of the specific 
parameters that were estimated from the data.  ‘B’ denotes the fixed effects, ‘U’ 
the random effects, and ‘e’ the error term.    The Z refers to a set of indicator 
variables denoting the ‘batch effect’, referring to the four separate experimental 
trials included in the analysis.    The X is denoted as either Global® or 
P1®_Multiblast®, and ‘Y’ the specific category of analysis.  Any p <  0.05 was 
considered statistically significant.  
 A logistic regression analysis, using SAS 9.22 PROC LOGISTIC software, 
was utilized to statistically compare embryonic development of D3 and D5 of 
embryos between the P1®_Multiblast® and Global® medium systems.    The 
ratios of hatching/hatched:unhatched blastocysts, TE:ICM counts, and abnormal 
nuclei:normal nuclei counts were also compared through this same analytical 
approach.  The statistical model is set up as follows:  log(P(Y = 1)/P(Y = 0 )= 
XB+ZU+e.  The left side of the equation, displayed as log(P(Y = 1)/P(Y = 0), is 
known as the log odds, and takes the binomial nature of the data into 
consideration.  All basic terms in the equation are defined similarly as in the 
previous paragraph.  A p < 0.05 was considered significant.  Statistical 
comparisons between the P1®_Multiblast® and Global® embryos are displayed 
as Odds Ratios for each of the aforementioned categories.   An Odds Ratio is the 
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ratio of the probability of an event occurring, to the probability of that same event 
not occurring.  
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COMPONENTS 
 
P-1® 
(Step 1) 
Multiblast® 
(Step 2) 
Global® 
 
Sodium Bicarbonate X X X 
Phenol Red X X X 
Sodium Pyruvate X X X 
Taurine X X   
Gentamycin X   X 
Gentamicin Sulfate   X   
Sodium Chloride X X  X 
Calcium Chloride X X X 
Potassium Chloride  X X X 
Sodium Citrate X X   
Sodium Lactate X X X 
Magnesium Sulfate X X X 
Potassium Phospate   X X 
Glucose   X X 
EDTA     X 
Alanyl-glutamine   X X 
Alanine   X X 
Asparagine   X X 
Aspartic Acid   X X 
Glutamic Acid   X X 
Glycine   X X 
Proline   X X 
Serine   X X 
Arginine   X X 
Cysteine   X X 
Histidine   X X 
Isoleucine   X X 
Leucine   X X 
Lysine   X X 
Methionine   X X 
Phenylalanine   X X 
Threonine   X X 
Tryptophan   X X 
Tyrosine   X X 
Valine   X X 
 
     Osmolity 
(mOsm)/pH/Temperature (°C) 
290/7.3/37 290/7.3/37 270/7.25/37 
   1 
Concentration of components are proprietary 
 
2 
Media are from Irvine Scientific (P-1® and Multiblast®) and LifeGlobal (Global®)  
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Figure 3.1: Nuclear Morphology.  Original magnification 600X. Pyknosis 
(shrinking/condensation) and karyorrhexis (disinigration/granulation) are forms of 
nuclear damage, and are identified in this blastocyst with red arrows.   
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Figure 3.2: Hatching vs. Unhatched Blastocysts. Original magnification 600X.   (A)  
A hatching blastocyst.  A breach in the ZP can be observed (red circle). (B)  An 
unhatched blastocyst.  A fully intact ZP is present (red arrow). 
                        Hatching                                                        Unhatched 
A B 
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Figure 3.3:  Timeline of Murine Embryo Culture.  Timeline of murine embryo 
collection, culture, and fixation.   
= Embryo Collection 
 
   
= Change Media 
 
 
 -   -  -  -   
Culture Single 
Medium  + HCO
3
-
 
Culture Sequential   
Media + HCO
3
-
 
 
Collection  
mHTF + HEPES 
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RESULTS 
 
Total Blastocyst Nuclei Number 
 Total blastocyst nuclei number was significantly higher in embryos that 
were grown in single medium as compared to those grown in sequential media.  
Single media blastocysts had on average had 35 more total nuclei than the 
sequential media blastocysts (Figure 3.4 and Table 3.2).   
ICM and TE Nuclei Number 
While there was no significant difference in the average number of 
presumptive ICM nuclei per blastocyst between the single medium and the 
sequential media groups, the single media group had a significantly higher 
average number of presumptive trophoblast nuclei per blastocyst (Figure 3.5 and 
Table 3.3a).  There was also a significant difference in the ratio of presumptive 
TE nuclei: presumptive ICM nuclei per blastocyst between the two groups, with 
single media being 1.7X more likely to maintain a higher TE:ICM ratio compared 
to sequential media. This is expressed as an Odds Ratio in Table 3.3b. 
Abnormal versus Normal Nuclei Number 
There was no significant difference in the average number of abnormal 
nuclei per blastocyst between the single medium and the sequential media 
groups (Figure 3.6 and Table 3.4a).  Further, there was no significant difference 
observed in the ratio of abnormal nuclei:normal nuclei per blastocyst between 
either of the two groups.  This is expressed as an Odds Ratio in Table 3.4b. 
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Unhatched vs. Partially/Fully Hatched Blastocysts 
 There was a statistically higher number of total hatched/hatching 
blastocysts found in the single medium when compared to the sequential media 
(Figure 3.7 and Table 3.5a) (p-value not shown).  Further, there was a significant 
difference in the ratio of hatched/hatching blastocysts:unhatched blastocysts 
between the two groups.  The single medium was 8X more likely to develop a 
hatching/hatched blastocyst when compared to the sequential system.  This is 
expressed as an Odds Ratio in Table 3.5b. 
Development on D3 or D5 
 Murine embryos should be at the 8 cell stage or greater on developmental 
D3.  Zygotes that were grown in the single medium did not show a statistical 
difference in the number of embryos ≥ 8C stage vs. those <8C stage compared 
to those grown in the sequential media on developmental D3 (Figure 3.8 and 
Table 3.6a).  The ratio of ≥ 8C stage : <8C stage was also non-significant.  This 
is expressed as an Odds Ratio in Table 3.6b.  Murine embryos should be at the 
blastocyst stage on D5 in vitro.  The zygotes that were grown in the single 
medium showed a statistical difference in the ratio of blastocyst to morula stage 
embryos when compared to the sequential medium.  This is expressed as an 
Odds Ratio in Table 3.6b.  The odds of observing a D5 blastocyst-stage embryo 
in the single medium are 3.65X the odds of observing a blastocyst-stage embryo 
in the sequential media.  Also, single medium exhibited a statistically higher total 
number of blastocysts when compared to the sequential media on D5 (Figure 3.8 
and Table 3.6a).   
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Figure 3.4:  Mean Nuclei Count Per Blastocyst1,2 
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Values within each bar denote the total number of blastocysts that were analyzed per 
each group (corresponding to Table 3.2) 
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  Sequential Single 
Mean Number of Nuclei           
(x¯ ±SEM) 56 ± 7.0 91  ± 6.8* 
N = straws (blastocysts)  4 (34) 4 (46) 
Table 3.2:  Mean Nuclei Count Per Blastocyst 
*
Statistically different between sequential and single (p < 0.05) 
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Values within each bar denote the total number of blastocysts that were included 
per each group (corresponding to Table 3.3a) 
 
Figure 3.5:  Mean Number of TE and ICM Nuclei Per Blastocyst1,2 
2 
p-value is comparing the TE:ICM ratios between groups  (p < 0.05 is significant) 
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 Sequential Single 
Mean Number of TE Nuclei  
(x¯ ±SEM) 
41 ± 5.5
a 73 ± 5.7b 
Mean Number of ICM 
Nuclei (x¯ ±SEM) 
17.8 ± 1.2
a 19.1 ± 1.1a 
N= straws (blastocysts) 4 (29) 4 (37) 
 p-value Odds Ratio 
Single vs. Sequential <0.0001 1.7 
Table 3.3a:  Mean Number of TE and ICM Nuclei Per Blastocyst1 
Table 3.3b:  Mean Number of TE and ICM Nuclei Count Odds Ratio Analysis1 
1 
a,b:  Different letters across the same row indicate significant  
differences (p < 0.05) 
 
1
 p < 0.05 is significant 
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Figure 3.6:  Mean Number of Abnormal and Normal Nuclei Per Blastocyst1,2 
1 
Values within each bar denote total number of blastocysts that were analyzed per 
each group (corresponding to Table 3.4a) 
 2 
p-value refers to the Odds Ratio Analysis (p > 0.05 is nonsignificant) 
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 Sequential Single 
Mean Number Abnormal 
Nuclei (x¯ ±SEM) 
6 ± 0.3 4 ± 0.3 
Mean Number Normal Nuclei 
(x¯ ±SEM) 
52 ± 3.6 84 ± 3.8 
N= straws (blastocysts) 4 (32) 4 (46) 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 p-value Odds Ratio 
Sequential vs. Single 0.4 0.9 
Table 3.4a:  Mean Number of Abnormal and Normal Nuclei Per Blastocyst 
Table 3.4b:  Abnormal versus Normal Nuclei Per Blastocyst Odds Ratio Analysis1 
1
 p > 0.05 is nonsignificant 
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Values within each bar denote the total number of blastocysts that were 
included per each group (corresponding to Table 3.5a) 
 
 Figure 3.7: Percentage of Hatched/Hatching Blastocysts1,2 
2 
p-value refers to the Odds Ratio Analysis (p < 0.05 indicates significance) 
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  Sequential Single 
Total Number of 
Hatched/Hatching  
Blastocysts  
10.0 37.0 
Total Number of 
Unhatched Blastocysts 23 9 
N= straws (blastocysts) 4 (33) 4 (46) 
 p-value Odds Ratio 
Single vs. Sequential <0.0001 8.9 
 
   Table 3.5b: Odds Ratio Analysis of Hatched/Hatching versus 
Unhatched Blastocysts1 
Table 3.5a:  Total Number of Hatched/Hatching and Unhatched Blastocysts 
1
 p < 0.05 is significant 
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Figure 3.8:  Percentage of Embryos at ≥ 8C (D3) or Blastocyst (D5) Stage1,2 
 1 Values within each bar denote the total number of blastocysts that were included                               
per each group (corresponding to Table 3.6a) 
 2 
p-values refer to the Odds Ratio Analyses (p < 0.05 is significant).  Comparisons were 
made between the Single and Sequential groups on either D3 or D5   
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p < 0.06 p < 0.0007 
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 D3 D5 
Sequential Single Sequential Single 
Total Number ≥8C Stage 
Embryos (D3) 
65 73 NA NA 
Total Number  <8C Stage 
Embryos (D3) 
21 10 NA NA 
Total Number Blastocysts 
(D5) 
NA NA 53 71 
Total Number <Blastocysts 
(D5) 
NA NA 33 12 
N=straws (embryos) 4 (86) 4 (83) 4 (86) 4 (83) 
 p-value Odds Ratio 
Single vs. Sequential (D3) 0.058 2.4 
Single vs. Sequential (D5) 0.0007 3.7 
Table 3.6a:  Total Number of Embryos at ≥ 8C (D3) or Blastocyst (D5) Stage 
Table 3.6b:  Odds Ratio Analysis of Developmental D3 and D5 Embryos1 
 
 
1
 p < 0.05 is significant 
 
 
\\ 
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DISCUSSION  
 Culture in single medium resulted in blastocysts with a greater total 
number of nuclei, more blastocysts, more hatched blastocysts and a higher 
proportion of trophoblast nuclei to ICM nuclei compared to those grown in 
sequential media.    This data suggests one of two potential conclusions:  (1)  the 
sequential system contains a mixture of components that restricts murine embryo 
development or (2)  the single culture environment is more conducive to embryo 
growth. 
Others have observed that murine, bovine, and porcine embryos that 
rapidly divide in vitro (developing a higher nuclei number) tend to be of a higher 
quality compared to those that do not [McLaren and Bowman 1973; Grisart et al. 
1994; Lonergan et al. 1999].  These same embryos displayed significantly higher 
birth and pregnancy rates when transferred, as well.  Also, a 2008 study by Luna 
et al. reported that faster cleaving D3 human embryos tended to develop to a 
higher quality D5 blastocyst than those dividing slowly, showing a greater degree 
of blastocoel expansion and higher quality ICM and TE morphological scores 
[Luna et al. 2008].  These same embryos also trended toward displaying a higher 
birth rate after being transferred.  Relating these previous findings with our own, 
it seems logical to conclude that growth in the tested single medium leads to a 
higher quality blastocyst than development in the sequential media.  As reported 
in our results, the trophoblast nuclei contributed to the significant difference 
observed in the average total blastocyst nuclei number between single and 
sequential media groups.   
139 
 
It has been reported that an increased number of trophoblast nuclei leads 
to a more complete and cohesive TE layer, predictably improving the ability of 
the developing embryo to undergo cavitation [Aplin 2000; Ahlstrom et al. 2011].  
The increased number of TE nuclei corresponds to an elevated level of Na+/K+ 
ATPase activity, and aquaporin channel accumulation, potentially contributing to 
the elevated rate of fluid accumulation and blastocoel formation [Ahlstrom et al. 
2011].  The significantly higher number of TE nuclei in the single medium group 
blastocysts potentially leads to a higher rate of blastocoel expansion.  Further, 
this may explain the increased number of hatching/hatched blastocysts observed 
in the Global® over the P1®_Multi® group.    
Trophectoderm that is made up of a cohesive layer of many small cells is 
associated with a higher quality blastocyst, as compared to TE which has a loose 
layer of larger cells [Ahlstrom et al. 2011].  This information further suggests that 
the tested single culture medium is more successful at nourishing 
preimplantation development when compared to the sequential media, based on 
the significantly higher number of trophoblast nuclei.  
 One explanation behind the differences observed in embryo quality 
between the single and sequential media may be their composition.  The early 
stage media of the sequential system lacks amino acids, glucose, and EDTA.  
Along with being involved in protein production, amino acids have been known to 
serve as osmolytes, regulators of intracellular pH and ROS protectants [Miyoshi 
et al. 1995; Biggers et al. 2000; Van Winkle 2001; Gardner 2008; Baltz 2012].  
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These functions are predominantly associated with glycine and glutamine [Baltz 
2012].   
There are mouse studies that have observed that exposing early stage 
embryos to a pool of amino acids for just a brief period of time improves 
developmental rates by nearly 20% [Biggers et al. 2000].  Early stage amino acid 
treatment has been associated with increased blastocyst cell number and a 
decreased incidence of apoptotic cellular death, as well [Hardarson et al. 2003]. 
Glutamine, which is a known substrate of the glycine transporter GLY1 
(expressed predominantly in pre-compacted embryos), is metabolized to 
glutamate, a precursor of nucleic acids, and alpha-ketoglutarate, a primary citric 
acid cycle intermediate [Gardner and Lane 1996; Hashimoto et al. 2008].  A lack 
of early stage amino acid supplementation may lead to the sequential media 
embryos to be more susceptible to external stressors, and exhibit a suboptimal 
metabolism.   This may either lead to increased embryotoxicity, or a delay in 
blastomere cleavage rates.     
Early stage exposure of mouse embryos to glucose has been associated 
with an upregulation of GLUT1, an important glucose transporter present 
throughout all stages of development, along with monocarboxylate transporter 1 
(MCT1), a pyruvate/lactate transporter [Purcell and Moley 2009].  Glucose is also 
known to be taken up by pre-compaction embryos at a fairly low rate in many 
species in vivo, ranging from bovine to rodent, and contributing to the 
accumulation of biomass necessary for proper growth and development (e.g.  
glucose-6-phosphate, which is shuttled into the pentose phosphate pathway).  It 
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is predictive that the early exposure of embryos to glucose in the single medium 
contributed to their increased developmental potential.  This could, in turn, be 
due to the improved ability of these same embryos to take up glucose at all 
embryonic stages.  
 Interestingly, based on light microscopic image analysis, single and 
sequential media were not statistically different in the number of embryos 
reaching ≥8-cell stage on developmental D3.  Rather, differences in development 
were first observed on D4 and D5.  This may indicate that in these studies, 
embryonic phenotypic anomalies do not manifest themselves until after D3 of in 
vitro embryonic development.  This information further points to the idea that the 
sequential system somehow disrupts proper blastocyst formation, potentially 
involving abnormal metabolite uptake throughout all stages of development.  This 
may be influenced by a lack of important components in the early stage medium 
of the sequential system.  Alternatively, it is possible that the first medium in the 
sequential pair was insufficient to provide developmental cues for the embryo to 
develop past the 8-cell stage. 
The percentage of presumptive ICM nuclei per blastocyst was not 
significantly different between the two groups.  This suggests that cellular 
differentiation and migration may not be impacted in one culture system versus 
the other.  Caution should be taken in interpreting this last finding due to the fact 
that TE and ICM nuclei were not differentially stained and could not be 
completely distinguished from one another during the counting protocol.   
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 It is possible that the greater number of trophoblast nuclei observed in the 
blastocysts developing in the single media may lead to improved implantation 
due to the increased surface area of the TE that is able to associate with the 
endometrium.  Another benefit of a blastocyst having a higher TE nuclear 
number is the subsequent development of a more robust placenta, leading to the 
increased nourishment of the fetus in utero.   
In conclusion, the sequential media may not be the best choice in the 
context of ART, in comparison to single media, when choosing a culture system 
for human preimplantation embryo development.  Single culture media may lead 
to higher quality blastocysts and is easier to prepare.  More side-by-side 
comparisons must be performed, using mouse embryo assays, in order to further 
conclude which media type and manufacturer is most optimal.  It is also possible 
that certain media types may be more conducive to human embryo development 
when compared to murine embryo development, and vice versa.  This must be 
taken into consideration when interpreting the results of a murine embryo assay.   
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